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ABSTRACT 
 New methods to measure and quantify tissue molecular composition and 
metabolism are a major driver of discovery in basic and clinical research. Optical methods 
are well suited for this task based on the non-invasive nature of many imaging and 
spectroscopy techniques, the variety of exogenous fluorescent probes available, and the 
ability to utilize label-free endogenous absorption signatures of tissue chromophores 
including oxy- and deoxy-hemoglobin, water, lipid, collagen, and glucose.  
Despite significant advances in biomedical imaging, there remain challenges in 
probing tissue information in a fast, wide-field, and non-invasive manner. Moreover, 
quantitative in vivo mapping of endogenous biomarkers such as water and lipids remain 
relatively less explored by the biomedical optics community due to their characteristic 
extinction spectra, which have distinct spectral features in the shortwave infrared, a 
wavelength band that has been traditionally more challenging to measure.  
The work presented in this dissertation was focused on developing instrumentation 
and algorithms for non-invasive quantification of tissue optical properties, fluorophore 
concentrations, and chromophore concentrations in a wide-field imaging format. All of the 
imaging methods and algorithms developed in this thesis extend the capability of the 
 
 vii 
emerging technique called Spatial Frequency Domain Imaging (SFDI). First, a new 
imaging technique based on SFDI is presented that can quantify the quantum yield of 
exogenous fluorophores in tissue. This technique can potentially provide a new non-
invasive means for in vivo mapping of local tissue environment such as temperature and 
pH. Next, an angle correction algorithm was developed for SFDI for more accurate 
estimation of tissue optical properties as well as chromophore concentrations in highly 
curved tissue, including small animal tumor models. Next, a wide-field label-free optical 
imaging system was developed to simultaneously measure water and lipids using the 
shortwave infrared (SWIR) wavelength region. Last, to break the bottleneck of processing 
speed in optical property inversion, new deep learning based models were developed to 
provide over 300× processing speed improvement. 
Together, these projects substantially extend the available contrasts and throughput 
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CHAPTER ONE: INTRODUCTION 
1.1: Motivations 
 Spatial Frequency Domain Imaging (SFDI) is an emerging wide-field imaging 
technique that allows for the extraction of tissue optical properties (i.e., absorption and 
reduced scattering) at visible and near-infrared (NIR) wavelengths. It uses projections of 
simple illumination patterns to determine the optical modulation transfer function (MTF) 
of biological tissue in the diffusive regime, which can be converted to optical properties 
using an appropriate inverse model. SFDI can be used to determine chromophore 
concentrations if optical absorption is determined at multiple wavelengths. It is currently 
being explored for a number of clinical and preclinical applications. The motivations of 
this dissertation are extending endogenous contrast, quantifying exogenous contrast, and 
improving processing throughout with SFDI.  
Recently, our group has begun to evaluate the use of SFDI for small animal tumor 
imaging, with a focus on monitoring treatment response. To date, most work in this area 
has focused on extraction of tumor oxyhemoglobin and deoxyhemoglobin concentration to 
monitor and track tumor metabolism and blood supply. Other endogenous chromophores, 
such as water, lipid, and collagen, are less explored, and may serve as relevant biomarkers 
of chemotherapy response.1–6 Water and lipids are indicators of important biophysical 
processes and several previous clinical studies have shown that these parameters differ 
significantly in tumors compared to normal tissues. For example, malignant breast tumors 
have lower mean bulk lipid composition compared to surrounding normal breast tissue. 




Recent work has shown that different lipid compositions can be identified using 
hyperspectral Stimulated Raman Scattering (SRS), and it may also be feasible to identify 
different lipid compositions with Diffuse Optical Spectroscopy.7–9 Past spectroscopy 
studies involving lipids and water have generally utilized the lipid absorption peak at 930 
nm and the strong water peak at 970 nm. While substantially less explored, the lipid 
absorption peak at 1210 nm is stronger (higher extinction) than the 930 nm peak and may 
be less obstructed by water absorption in biological tissue.10,11 In addition, collagen is 
another important biological component in tumor evolution and chemotherapy treatment. 
For example, collagen-dense breast tissue increases the risk of breast carcinoma,12,13 and 
aligned collagen has been found as a prognostic signature for survival in human breast 
carcinoma.6 It has been shown in clinical studies that collagen content is an important 
indicator for non-invasive assessment of breast cancer risk, and statistically significant 
discrimination exists in terms of collagen content between breast benign lesions and 
tumors.14–17 Furthermore, it has been shown that adding collagen is important for accurate 
in-vivo determination of endogenous chromophores.18 Although less explored, collagen 
may also be highly relevant for monitoring of treatment response in clinical and preclinical 
settings.  
In addition, with the ability to map wide-field tissue optical properties, in vivo 
fluorescence may be corrected to quantify fluorophore quantum yield. When quantum yield 
changes with temperature or pH, this can be used as an indicator of the local tissue 
environment.  




data to optical properties has become the bottleneck for real-time tissue information 
extraction. This is also true for some other optical technologies such as digital diffuse 
optical spectroscopic imaging (dDOSI). Essentially, the current inverse methods are 
mapping the measured or calibrated data to an optical property. Therefore, with recent 
thriving deep learning technologies, faster inverse models based on deep neural networks 
can potentially be developed to speed up inversion for the extraction of tissue information. 
The proposed dissertation work aims to develop and validate instrumentation and 
algorithms to fit this need. 
 
1.2 Chapter Summaries 
All the work presented in this dissertation focuses on quantification of tissue 
information using near-infrared (NIR) and shortwave-infrared (SWIR) light, with a 
combination of instrumentation and algorithms. Chapter 2 provides background and 
significance on diffuse optical imaging technology, related applications, and chromophore 
extraction techniques for tissues. Chapter 3 introduces a quantum yield imaging technique 
for fluorophores, which could potentially allow in vivo mapping of tissue local 
environment, such as temperature and pH. Chapter 4 improves the SFDI technology by 
providing an advanced angle correction method with convex optimization algorithms. 
Chapter 5 highlights the novel SWIR wavelength region for simultaneous mapping of 
tissue water and lipid content, and demonstrates biomedical applications on small animal 
models as well as on humans. Chapter 6 introduces a superfast inversion method for the 









CHAPTER TWO: BACKGROUND AND SIGNIFICANCE 
 This chapter presents the background and significance of diffuse optical imaging in 
the context of biomedical applications such as chemotherapy response monitoring, a major 
focus of our research group. Details of SFDI technology are introduced as well as methods 
to quantitatively extract tissue optical properties and chromophores.  
 
2.1: Chemotherapy Response Monitoring 
 Together with surgery and radiation therapy, chemotherapy is one of the three most 
common treatments for solid tumors.19 Chemotherapy refers to the use of drugs for cancer 
treatment. For many solid tumors, chemotherapy response can be monitored by measuring 
tumor volume using PET, ultrasound, MRI, or CT.20 It is valuable to know early if 
treatment is working, because ineffective therapies cause unwarranted side-effects that may 
be life threatening, and may lead to worse outcomes (e.g. shorter survival). In addition, 
continual monitoring also allows for the detection of therapy resistance. Existing methods 
for monitoring chemotherapy response include biopsy, MRI, PET, and CT. However, they 
are unable to longitudinally track therapies at frequent time points. For example, biopsy is 
invasive and there may be sampling errors. MRI, PET and CT are costly, and require 
ionizing radiation and/or exogenous agents. 
A non-invasive method is needed for tracking earlier metabolic, functional, and 
molecular response to chemotherapy. Diffuse Optical Spectroscopy (DOS) does this by 
measuring endogenous chromophores.21 Endogenous chromophores include oxygenated 




concentration, useful information can be derived about tissue physiological activities (e.g. 
tissue oxygenation) as well as treatment efficacy.22 Currently most work in this area has 
focused on extraction of tumor oxyhemoglobin and deoxyhemoglobin concentration to 
monitor and track tumor metabolism and blood supply.3,22 In contrast, water, lipid, and 
collagen are less explored as endogenous chromophores, while they may serve as relevant 
biomarkers of chemotherapy response.1–6 
Water and lipids are indicators of important biophysical processes and several 
previous clinical studies have shown that these parameters differ significantly in tumors 
compared to normal tissues. For example, water content is an important indicator for edema 
and inflammation, and is elevated in brain tumors.23 In addition, malignant breast tumors 
have lower mean bulk lipid composition compared to surrounding normal breast tissue. 
During treatment, lipid composition generally increases in chemosensitive breast tumors.3 
Recent work has shown that different lipid compositions can be identified using 
hyperspectral Stimulated Raman Scattering (SRS), and it may be feasible to identify 
different lipid compositions with diffuse optical techniques as well.7,21 However, SRS is a 
microscopic technique with high spatial resolution but small field of view, whereas SFDI 
samples a larger volume of tissue which is more clinical relevant. 
 Collagen is an important biological component in tumor evolution. For example, 
previous studies have shown that collagen-dense breast tissue increases the risk of breast 
carcinoma, and aligned collagen has been found as a prognostic signature for survival in 
human breast carcinoma.6,12,13 It has been shown in clinical studies that collagen content is 




significant discrimination exists in terms of collagen content between breast benign lesions 
and tumors.14–17 It has been demonstrated that DOS can identify collagen content in 
biological tissues, but as discussed earlier, DOS can only provide point measurements.14 
 
2.2: Small Animal Endogenous Imaging in Oncology 
Oxy- and deoxy-hemoglobin, water, lipids, and collagen have all been shown to be 
important in clinical oncology.3,6,23,24 In order to improve clinical practice, small animal 
imaging is needed to better test biological hypotheses regarding treatment response and 
new drugs. However, current small animal imaging techniques are not capable of extracting 
and tracking hemoglobin, water, lipids, and collagen simultaneously and most prior small 
animal tumor monitoring has focused solely on hemoglobin based parameters. 25 The 
ability to extract more clinically relevant chromophores in the preclinical setting may better 
help translate new discoveries related to drug scheduling, new therapies, resistance 
mechanisms, and other important aspects to the clinic using DOS technology.  This 
dissertation focuses on a new diffuse optical imaging method called Spatial Frequency 
Domain Imaging (SFDI) that is well-suited to small animal imaging. Additionally, the 
same optical parameters measured with SFDI are directly translatable to the clinic using 
technologies such as DOS or DOT. 
 
2.3: Spatial Frequency Domain Imaging (SFDI) 
The details of SFDI image acquisition and processing have been described in detail 




Fig. 2.3.1. Briefly, SFDI utilizes spatially modulated sinusoidal light patterns of visible or 
near-infrared light, projected at different spatial frequencies and wavelengths, to separate 
the relative contributions of absorption and scattering in diffusive media. Raw reflectance 
images are sequentially measured, demodulated, and calibrated to create diffuse reflectance 
maps, with pixel values normalized between 0 and 1. Diffuse reflectance (Rd) maps are 
created for each wavelength and each spatial frequency. The spatial frequency dependence 
of Rd at each pixel (i.e. the Modulation Transfer Function) then serves as the input to an 
inverse model, in this case a Monte-Carlo based look-up table method, which provides 
pixel-by-pixel optical absorption and reduced scattering values.28 
Key to the extraction of normalized Rd maps is the calibration of the demodulated 
raw image data (Mac) against a calibration phantom with known optical properties. The 
calibration phantom is first measured with the SFDI system, and a forward model is used 
to determine the expected Rd values based on prior optical property knowledge. A second 
phantom or tissue-of-interest (with unknown optical properties), is then imaged using the 
same spatial frequencies and wavelengths, and calibrated Rd maps are produced using Eq. 
(1), which removes the instrument response.  
(1) 
 
Rd and Mac refer to diffuse reflectance and demodulated maps, respectively, and subscripts 
tis and ref refer to the tissue and calibration phantom, respectively.27 
In some cases, additional corrections are required for measurements of tissue with 
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perturbations caused by height variation, a height correction method was previously 
developed.29 Briefly, a calibration phantom is measured at multiple heights and the 
demodulated data (Mac) at each height is extracted. Then, a height map of the object or 
tissue of interest is acquired using optical profilometry. A new Mac,ref  map is then calculated 
by adjusting the Mac values, pixel by pixel, according to the height versus Mac relationship 
determined from the multi-height calibration measurements. This Mac data is used to 
replace the calibration Mac,ref  term in Eq. (1). The effect of height correction is to create a 
virtual calibration phantom such that it has the same pixel-wise height as the object.  
 




2.4: SFDI Pre-clinical and Clinical Applications 
After optical properties at multiple wavelengths are measured, tissue chromophore 
concentrations can be extracted to help identify disease states, therapy response, and tissue 
metabolic function. SFDI is being explored for a number of pre-clinical and clinical 
applications, including skin flap viability, burn wound healing, and subsurface 
tomography, with the imaging wavelength in the range of 400 nm – 980 nm.30–43 
Specifically, in Sharif et. al., SFDI has been used to compare oxygen saturation 
before and after treatment of port-wine stains.31 In Gioux et al., an SFDI imaging system 
was applied as a “non-significant risk” device in a clinical trial for measuring hemoglobin 
concentration.32 In Rohrbach et. al., a clinic-friendly SFDI system was used to measure 
oxy- and deoxy-hemoglobin concentrations, as well as total hemoglobin and oxygen 
saturation for non-melanoma skin cancer.34 
2.5: Limitations and Improvements of SFDI 
While SFDI is increasingly being adopted for both preclinical and clinical studies, 
we have identified several areas of opportunity for substantially improving this technique 
in terms of contrasts, accuracy, and throughput.  These areas are briefly described here, 
and then addressed in depth in each chapter of the thesis.   
2.5.1: Combining exogenous and endogenous contrasts with SFDI 
While SFDI can provide widefield maps of endogenous contrasts such as oxy- and 
deoxy-hemoglobins, exogenous fluorescence contrast is less explored. The combination of 
endogenous and exogenous imaging techniques may be able to better quantify tissue 




can potentially be used as a microenvironmental biomarker. 
2.5.2: SFDI Imaging Artifacts in Small Animal Tumor Models  
 SFDI is widely used in preclinical imaging such as small animal tumor monitoring. 
However, due to small feature size and highly curved surface geometry (high angles), SFDI 
suffers from imaging artifacts near the edge and border of these curved surfaces. Therefore, 
a correction method is needed for such circumstances. 
2.5.3: Imaging Water and Lipids  
Current SFDI measurements on endogenous contrast are focused on chromophores 
such as oxy- and deoxy-hemoglobins and in the wavelength range of near-infrared. Other 
important biomarkers such as water and lipids, are not available with existing SFDI 
modalities, due to limited imaging wavelengths.   
The absorption spectra of chromophores including water, lipid, oxy- and deoxy-
hemoglobin have been described in previous literature, as shown in Fig. 2.5.1.44,45 
Chromophore concentrations can be calculated by fitting optical absorption, which is better 
done at wavelengths where individual chromophores have high absorbance and not 
obscured by other chromophores.46 Past spectroscopy studies involving lipids and water 
have generally utilized the lipid absorption peak at 930 nm and the strong water peak at 
970 nm. While substantially less explored, the lipid absorption peak at 1210 nm is stronger 
(higher extinction) than the 930 nm peak and may be less obstructed by water absorption 
in biological tissue.10,11 Although the lipid 1210 nm peak is still influenced by a nearby 




absorption is stronger than neighboring chromophores. Studies have also shown notable 
SWIR absorption features of tissue constituents including water (near 1150, 1450 nm, and 
1900 nm), lipids (near 1040, 1200, 1400, and 1700 nm), and collagen (near 1200 and 1500 
nm) that are much more prominent than their counterparts in the visible and near-infrared 
(~400 to 1000 nm).47,48 Therefore, conducting SFDI in this wavelength range (e.g. for this 
dissertation, up to 1300 nm) has the potential to provide enhanced sensitivity to 
chromophores such as water and lipids.  
 
Figure 2.5.1: (a) Absorption spectra of deoxyhemoglobin (Hb), oxyhemoglobin (HbO2), lipid, and 
water (650 – 990 nm) 44. (b) Absorption coefficient spectra of chromophores including lipid, water, 
and collagen (900 – 1300 nm) 45. Note that the absorption spectrum of elastin is for demonstration 
purpose only, and its concentration extraction is beyond the scope of this proposal. 
 
2.5.4: Bottleneck in SFDI processing  
While SFDI data collection can be relatively fast, the data processing from 
measured diffuse reflectance to optical property maps becomes the bottleneck of speed. 




numerical interpolation at each pixel of the measured maps. In order for real-time feedback 





CHAPTER THREE: ENHANCED FLUORESCENCE IMAGING FOR PROBING 
LOCAL ENVIRONMENT IN DIFFUSIVE MEDIA 
 Fluorescence imaging with exogenous probes is widely used for preclinical and 
clinical applications. However, due to effects of tissue absorption and scattering, 
conventional planar fluorescence imaging is non-quantitative and cannot extract 
fluorophore quantity or fluorescence efficiency (also known as quantum yield). This 
chapter presents an enhanced quantitative fluorescence imaging technique that is able to 
measure key parameters of the local tissue environment in diffusive media. This method 
utilizes SFDI to quantify tissue optical properties, which are then used to correct planar 
fluorescence images and extract widefield maps of fluorophore quantum yield. Since 
quantum yield is sensitive to the microenvironmental state (e.g. pH), this technique can be 
used to monitor these parameters in a new way. 
 
 The work in Chapter Three is published in the Journal of Biomedical Optics 39 with 
the following contributing authors: 
Yanyu Zhao,1 and Darren Roblyer 1 
1 Boston University, Department of Biomedical Engineering, 44 Cummington Mall, 
Boston, Massachusetts 02215, United States 
3.1: Introduction 
Optical imaging with the use of exogenous targeted fluorescent agents (i.e. 
Molecular Imaging) is increasingly used in the preclinical setting for understanding disease 




that excite and emit in the near-infrared (NIR) (600-1000 nm) allow for deep photon 
penetration (several mm’s) while minimizing tissue autofluorescence. Almost all 
commercially available fluorescence small animal imaging systems collect planer 
fluorescence light emission from the tissue surface.  One of the major drawbacks of these 
imaging setups is the inability to extract quantitative fluorescence signals or probe 
concentrations due to the effects of the surrounding tissue optical properties, namely 
absorption and scattering. Without additional correction for background optical properties, 
these systems are unable to provide fluorescence intensity maps that are quantitatively 
comparable between samples or animals. An additional complicating factor is that the 
intensity of the collected fluorescence is not only dependent on the fluorophore 
concentration, but also depends on the quantum yield (QY), which is defined as the ratio 
of emitted photons to absorbed photons in the respective emission and absorption 
wavelengths bands.50 For some fluorophores, the QY is highly sensitive to environmental 
conditions such as pH, temperature, oxygen concentration, and other factors.51–55 While a 
varying QY generally represents a challenge for quantitative fluorescence imaging, it also 
suggests that QY may be used as a novel microenvironmental biosensor if it can be 
accurately measured in vivo.  
In the laboratory setting, fluorescence QY is commonly determined by comparing 
the fluorescence intensity of a fluorophore with an unknown QY to a standard with known 
QY, with both samples measured in an optically dilute, non-scattering media.56–59 QY 
determination is more difficult in tissue due to the interaction of both the excitation and 




due to both absorption and scattering events. However, if the optical properties at both the 
absorption and emission wavelengths are known, established models allow for a 
quantitative fluorescence signal to be extracted.60–62 If one also assumes a known QY, 
quantitative fluorescence also allows for probe concentrations to be determined. In this 
work, we posit that if a priori knowledge of the probe concentration is available, the 
unknown probe QY can be determined.   
 We present here a quantitative wide-field imaging modality called Quantum Yield 
Imaging (QYI) that has the ability to spatially map the QY of a fluorophore in diffusive 
media such as tissue. QYI uses a combination of Spatial Frequency Domain Imaging 
(SFDI) and planar fluorescence imaging to accomplish this task.27 SFDI quantifies optical 
properties of the diffusive media at both the excitation and emission wavelengths, and is 
used to determine probe concentration using absorption contrast at the excitation 
wavelength. This information then feeds a modified quantitative fluorescence model that 
corrects the planar fluorescence raw signal intensity, producing a pixel-by-pixel map of 
QY values in a wide-field image.60,61 We demonstrate this method using tissue-mimicking 
optical phantoms and show that the QY of two fluorophores, rhodamine B, which is highly 
sensitive to its solvent composition, and SNARF-5, which is pH sensitive, can be 
quantitated and spatially mapped using QYI under a variety of experimental conditions and 
background optical properties. QYI may provide a new means to nondestructively 
determine important tissue microenvironmental parameters in vivo, such as local pH, 





QYI imaging combines SFDI and planar fluorescence with a modified empirical 
model of quantitative fluorescence. The details of each of these methods are outlined here 
as well as the overall methodology for combining their information outputs to generate QY 
maps. Then, the methodology for determining the accuracy of QYI is outlined, namely by 
extracting the QY of two fluorophores, rhodamine B and SNARF-5, each measured under 
a variety of experimental conditions.    
 SFDI is used to extract optical properties from the background media in QYI.  SFDI 
utilizes spatially modulated sinusoidal light patterns of visible or near-infrared light, 
projected at different spatial frequencies and wavelengths, to separate the relative 
contributions of absorption and scattering in diffusive media.27,60 Raw reflectance images 
are sequentially measured, demodulated, and calibrated to create diffuse reflectance maps. 
From these maps, optical properties (absorption and reduced scattering) can be extracted 
from each pixel in the image using a Monte-Carlo based look-up table method.28 This 
methodology has been implemented in multiple in vivo studies and has potential 
applications in subsurface tomography.36–38,60,61 For this study, we used the OxImager RS 
SFDI system (Modulated Imaging Inc., Irvine, CA). This system provides LED 
illumination at up to 11 wavelengths spanning the visible to NIR and images with a 15 cm 
× 15 cm field of view. The system response is determined with the use of a calibration 
silicone phantom of known optical properties. For data processing, both height and angle 
correction of SFDI are applied.29 For this study, SFDI measurements were taken at 526 




band of the fluorophores. The same light source and camera were used to collect planar 
fluorescence images with the addition of a cleanup bandpass filter with a center wavelength 
at 534 nm and a 30 nm passband. A longpass filter with a cutoff wavelength of 561 nm 
was used in the emission band.   
 While there are a variety of models available to extract quantitative fluorescence, 
in this work we utilized the model developed by Gardner et al.46,60,63 This model is an 
empirical approach based on semi-infinite, homogeneous Monte Carlo simulations. It 
accounts for the presence of tissue absorption and reduced scattering, assumes planar 
illumination, and is simplified to a one-dimensional (1D) problem. This model can be 
applied to an imaging geometry by separately analyzing each image pixel.36 SFDI provides 
µa and µs′ at both excitation and emission wavelengths, which are used as inputs to the 
model to calculate a fluorescence attenuation correction factor. This factor accounts for 
optical absorption and scattering, and is applied to a raw fluorescence planar image. The 
fluorescence correction factor is determined as follows: 
 
Cn and kn are defined in Table 1 of Gardner et al. as empirical coefficients.
61 They are 
dependent on the diffuse reflectance Rd. Since Rd is a function of µa and µs′, it can be 
calculated from the values determined by SFDI measurement. ẟ refers to optical 
penetration depth, which is calculated from µa and µs′: 𝛿(𝜆) = 1/√3𝜇𝑎(𝜆)[𝜇𝑎(𝜆) + 𝜇𝑠′(𝜆)]. 
A flowchart of QYI data processing is shown in Fig. 3.2.1. In general, the 
determination of an unknown QY requires knowledge of the fluorophore concentration, a 
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planar fluorescence map corrected for background optical properties, and the instrument 
response, which is a function of detector sensitivity, imaging geometry, and other 
instrument related parameters. In order to determine the unknown QY of a sample, the 
instrument response is first determined from a calibration phantom with known QY and 
known fluorophore concentration (top box of Fig. 3.2.1). This instrument response is then 
applied to the sample with unknown QY (bottom box of Fig. 3.2.1).  More specifically, 
first a calibration phantom with known QY is fabricated and SFDI is used to quantify the 
background optical properties of the diffuse sample over a wide-field area at both the 
absorption and emission wavelengths for a specific fluorophore. Then, SFDI is used again 
to determine the additional absorption (Δμa) at the excitation wavelength caused by the 
addition of an exogenous fluorophore to the sample. This Δμa is used to determine the 
concentration of the added fluorophore based on the known extinction coefficient at the 
excitation wavelength. The same information is also extracted from a sample phantom 
(with unknown QY). The background μa, µs′, and planar fluorescence data are then input 
into the Gardner model to produce a corrected fluorescence map. The corrected 
fluorescence map and the calculated probe concentration of the calibration phantom are 
compared to those of the sample phantom, so that the fluorophores QY can be extracted 
and mapped over a heterogeneous sample.  It is important to note that this methodology 
requires a stable absorption cross-section regardless of environmental conditions so that 
the probe concentration can be calculated despite any changes in QY.  Both fluorophores 





Figure 3.2.1: Flowchart of quantum yield imaging data processing. X1D is the fluorescent correction 
factor.  [Fluorophore] indicated the extracted fluorophore concentration. 
 The QY of many fluorescent dyes is known to change under different 
environmental conditions. Previous studies have shown that the QY of rhodamine B is 
sensitive to solvent effects.54 In mixed methanol-water solvents, its QY varies from 0.52 
to 0.30 while the methanol-water volume ratio changes from 100:0 to 0:100.54 SNARF-5 
(Life Technologies, Carlsbad, CA)  exhibits a significant pH-dependent emission shift 
between acidic and basic conditions and is commonly used as an intracellular pH 




 The absorption and emission spectra of both fluorophores were measured with a 
spectrophotometer (Cary 100 Bio UV-Vis, Varian, Palo Alto, CA) and a fluorimeter 
(FluoroMax 3, Horiba, Kyoto, Japan), respectively. For rhodamine B, nine samples were 
made with varied methanol-water volume ratios (99:1, 90:10, 80:20, 70:30, 60:40, 50:50, 
30:70, 10:90, and 0:100). For SNARF-5 measurements, nine samples with varied pH 
conditions were made (pH = 6.07, 6.39, 6.82, 7.11, 7.79, 8.13, 8.36, 8.88, and 9.30). The 
fluorophore concentration was 3 µM for all samples. For QYI experiments, measurements 
were conducted in liquid phantoms. The prepared liquid phantoms were poured into a 2.5 
× 2.5 × 2 cm well embedded in a diffuse silicone phantom. In the rhodamine B experiments, 
the liquid phantoms had water/methanol mixtures as the solvent, nigrosin as absorber, and 
titanium dioxide as the scattering agent. For SNARF-5 experiments, phosphate buffered 
saline (PBS) was used as solvent due to its low solubility in water. Nigrosin was used as 
the absorber and 1.1 µm polystyrene microspheres as the scatterer, and pH was varied by 
adding either hydrogen chloride (HCl) or sodium hydroxide (NaOH). The background 
optical properties were adjusted by varying the amount of absorbers and scatterers.   
 
3.3: Results 
Fig. 3.3.1 shows the absorption spectrum of rhodamine B plotted from 450 nm to 
650 nm, and the emission spectrum from 561 nm to 660 nm, with an excitation wavelength 
of 526 nm. 526 nm and 561 nm correspond to the center wavelength of the illumination 
LED in both SFDI and fluorescence modes, and the cutoff wavelength of the long-pass 




change the QY. Importantly, the absorption of rhodamine B was relatively stable while the 
emission changed dramatically with solvent. 
 
Figure 3.3.1: Rhodamine B excitation and emission spectra. 
 
Liquid Excitation wavelength: 526 nm 
Phantom   𝝁𝒂 (mm
-1) 𝝁𝒔′ (mm
-1) 
Phantom Set 1 0.028 0.55 
Phantom Set 2 0.022 1.04 
Phantom Set 3 0.051 0.53 
Phantom Set 4 0.045 0.99 
Phantom Set 5 0.074 0.51 
Phantom Set 6 0.070 0.96 
 





To validate the QYI method, a series of 54 liquid phantoms were prepared, each 
with different combination of solvent and optical properties. For simplicity, the 
concentration of rhodamine B was kept at 3 µM for all liquid phantoms. At each of the nine 
methanol-water mixture ratios (99:1, 90:10, 80:20, 70:30, 60:40, 50:50, 30:70, 10:90, and 
0:100), six liquid phantoms of varied optical properties were made (Table 1). Note that the 
background optical properties of the liquid phantoms were measured without the presence 
of fluorescent dye, after which the dye was added to the liquid phantoms and then the 
fluorescence intensities were measured. The fluorophore concentration was calculated by 
comparing optical absorption at the excitation wavelength before and after adding the 
fluorophore, and with knowledge of rhodamine B’s extinction coefficient at this 
wavelength. For each of the 54 liquid phantoms, the QY was determined by averaging 
within a region-of-interest (ROI) corresponding to each liquid phantom and comparing 
these to literature values as shown in Fig. 3.3.2. Each colored dot represents a separate 
liquid phantom and different dot colors correspond to unique excitation wavelength 
background optical properties. The solid black line indicates known QY’s from literature.54 
Calculated QY’s vary less than 10% from known values. Among the neighboring groups 
of the estimated QY’s (grouped by solvent composition), the following pairs, 99:1/80:20, 
80:20/60:40, 70:30/50:50, 50:50/30:70, 30:70/10:90, and 10:90/0:100, are statistically 
different, confirmed by Student’s t-test (p-value < 0.05).  Calibration phantoms were made 





Figure 3.3.2: Measured quantum yields vs. literature values (rhodamine B). 
 The QYI method also allows spatial mapping of QY on pixel-by-pixel basis. A 
series of 9 liquid phantoms were made and poured into 9 wells embedded in a diffuse 
silicone phantom. These 9 phantoms were imaged with SFDI and planar fluorescence, and 
pixel-level QY information was extracted as shown in Fig. 3.3.3. The middle panel shows 
raw fluorescence, which is highest in the liquid phantoms with the lowest background 
absorption (middle panel, left column).  The right panel shows QY spatial mapping, 
demonstrating that correct QY’s can be extracted regardless of background optical 
properties.  The predicted and measured average QY in each well were within a 10% 
agreement on average. The image processing for spatial mapping was performed in Matlab 
(Mathworks, Natick, MA). The optical property maps of the background phantom were 
denoised by a close operation with a disk-shape template of 5-pixel radius, followed by 
median filtering with a 5-by-5 neighborhood around each pixel. The computed QY maps 




accuracy for QY determination was 0.021. This was calculated by determining the 
differences between the measured QY’s and the literature values for each optical property 
combination, and then averaging over the entire experiment. 
 
Figure 3.3.3: Spatial mapping of quantum yield (rhodamine B). 
  
The QY of SNARF-5 was measured under varying pH conditions to demonstrate 
the ability of QYI to perform as a non-invasive pH indicator. First, the absorbance and 
emission spectra of SNARF-5 were measured under different pH conditions in non-diffuse 
media using a spectrophotometer and fluorimeter. Fig. 3.3.4 shows the absorption spectrum 
of SNARF-5 collected from 400 nm to 700 nm, and the emission spectrum from 561 nm 
to 850 nm, with excitation wavelength of 526 nm. The QY of SNARF-5 was calculated by 
comparing these measurements to the spectra of a rhodamine B sample with 50:50 
methanol-water solvent compositions. The rhodamine B sample has a known QY and was 
measured under the same spectrophotometer and fluorimeter settings. Results are listed in 
Table 2, which shows that the QY of SNARF-5 becomes larger with increasing pH. 















Table 2. SNARF-5 quantum yields vs. pH. 
 
 






QYI imaging of SNARF-5 was tested in a 4x4 set of liquid phantoms, with four pH 
conditions (pH = 6.07, 7.11, 8.36, and 9.30) and four different background optical property 
combinations. The pH was measured with a pH meter (Oyster-10, Extech Instruments, 
Nashua, NH). The optical properties of each of the four liquid phantoms are shown in Table 
3. For simplicity, the concentration of SNARF-5 was kept at 3 µM for all phantoms. QY’s 
were extracted and compared to standard values, as shown in Fig. 3.3.5. Each colored dot 
in Fig. 3.3.5 represents a liquid phantom and dot color indicates a unique combination of 
background optical properties. Calculated QY’s are within 20% of known values. This is 
inferior to the rhodamine B experiments (10%), likely due to the fact that SNARF-5 QY’s 
are generally much lower than those of rhodamine B, leading to larger percent differences. 
Calibration phantoms had a pH of 7.79. 
To demonstrate spatial mapping of QY for SNARF-5, a series of four liquid 
phantoms were measured, and pixel-level QY information was extracted, as shown in Fig. 
3.3.6. The right panel shows QYI spatial mapping. For the wells in the right panel, top row, 
the measured average QY’s are 0.22 and 0.26, with standard deviations (SD) of 0.025 and 
0.024, respectively. The expected QY for this row, based on spectrophotometer and 
fluorimeter measurements, was 0.22. The average measured QY’s of the bottom row are 
0.032 (SD=0.0031) and 0.038 (SD=0.0048), while the expected QY was 0.059. In general, 
SNARF-5 QY’s were determined with accuracy of 0.012 based on accuracy calculations 
averaged over all phantoms. The optical property and QY maps were processed in the same 





Liquid  Excitation wavelength: 526 nm 
Phantoms  𝝁𝒂 (mm
-1) 𝝁𝒔′ (mm
-1) 
Phantom Set 1 0.018 0.39 
Phantom Set 2 0.015 0.81 
Phantom Set 3 0.031 0.38 
Phantom Set 4 0.029 0.79 
 
Table 3. Background optical properties of liquid phantoms (SNARF-5). 
 
 
Figure 3.3.5: Measured quantum yields vs. standard values (SNARF-5). 
 




To illustrate a dynamic, time-varying spatial mapping of QY, a 160 ml liquid 
phantom was made in a 10.55 × 6.82 × 2.23 cm well embedded in a diffuse silicone 
phantom. SNARF-5 was added at a concentration of 3 µM, with phantom background 
optical properties of μa = 0.016 mm
-1 and μs′ = 0.533 mm
-1 at 526 nm. Sequential ml 
samples of 1M HCl or 1M NaOH were added from the upper left corner of the well with a 
pipette. HCl/NaOH diffused through the media, causing the local pH of the liquid phantom 
to change, and consequently the local QY. After the diffusion process, the liquid phantom 
was manually mixed and the pH was measured with a pH probe for validation. During this 
process, QY maps were collected and made at 3 second intervals, each frame had an 
integration time of 2 seconds. In order to link sample pH values to QY measurements, a 
sigmoid function was used to fit to data from Table 2. The fitted function is as follows: 
 
The pH of the sample was then extracted from QY values and a corresponding pH 
movie was created (supplemental Fig. 1 of the paper).39 The pH was measured by the pH 
probe four times in total. Before adding any HCl/NaOH, the pH was measured as 7.54, and 
the average pH from the extracted QYI pH map was 7.46 (SD=0.11). After adding 0.64 ml 
1M HCl and manual mixing, the pH was measured as 6.85, and the average pH from the 
pH QYI map was 6.74 (SD=0.17). Then, after adding another 0.64 ml 1M HCl and the 
manual mixing, the pH was measured as 6.17, and the average pH from the pH map was 
4.58 (SD=0.55). In the end after adding 1.28 ml 1 M NaOH and manual mixing, the pH 
was measured as 7.54, and the average pH from the pH map was 7.41 (SD=0.16). This 







dynamic process is shown in the supplemental movie 1 of the paper; Fig. 8 shows two 
frames from the movie.39 
 
Figure 3.3.7: Frames from supplemental movie: dynamic spatial mapping of quantum yield and pH. 
The SNARF-5 concentration was 3 µM, with background optical properties of μa = 0.016 mm-1 and μs' 
= 0.533 mm-1 at 526 nm. QY maps were collected and made at 3 second intervals while the fluorescence 
images were taken with exposure time of 2 seconds. The supplemental video has 316 total frames. (a) 
Baseline, no acid/base added. The baseline pH was measured as 7.54 with pH probe. (b) After 1M HCL 
added by pipette at the surface of the liquid phantom, acid is diffusing through the media, reducing 
the QY and pH of the solution. The movie plays at a speed of 9 times of the actual process, hence the 
text “Speed: 9 ×”. 
 
3.4: Discussion 
We have demonstrated a new imaging method, called QYI, which uses SFDI and 




diffusive background. QYI extends prior quantitative fluorescence methods which assume 
a constant and known QY for a given fluorophores of interest.28,61,62 By separately 
measuring fluorophore concentration in the relatively stable absorption band, we are able 
to determine the QY of the fluorophore by correcting raw planar fluorescence signal in the 
emission band, where fluorescence intensity changes greatly with environmental 
conditions. QYI was demonstrated using two fluorophores, rhodamine B and SNARF-5, 
which are sensitive to solvent and pH conditions respectively. The QY of these 
fluorophores was measured and validated in optical phantoms with different background 
optical properties.  Additionally, pixel-level mapping of optical properties with SFDI 
allowed for spatial mapping of QY for both of the fluorophores. Finally, a supplemental 
movie was made showing dynamic changes of both QY and environmental pH values using 
the SNARF-5 dye. 
The QY - pH relationship suggests one of the potential future applications of this 
method: mapping of local tissue pH in vivo using pH sensitive fluorophores. Due to 
absorption and scattering, measuring pH and other parameters is currently difficult in thick 
tissue. For example, pH is currently measured in tissue with either invasive probes or 
ratiometric pH dyes.54,64 Invasive probes have limited applicability to longitudinal studies, 
and ratiometric dyes may be unreliable in thick tissue due to the wavelength dependence 
of optical properties. There has been some work done in using fluorescence lifetime 
measurements to determine pH conditions in tissue, but this requires relatively complex 
and expensive pulsed laser systems and time-correlated single photon counting 




with pH sensitive dyes. Moreover, fluorophores which are sensitive to temperature, oxygen 
content, or protein binding can also be used with QYI, potentially allowing a variety of 
microenvironmental conditions to be determined non-invasively. 
Several assumptions were made in this study in order to simplify the processing 
required to generate QYI maps, and there are limitations to the use of this methodology for 
certain applications.  For example, the Gardner model assumes homogeneity in depth, 
which may limit the method’s use for some in vivo applications. Additionally, QYI requires 
the use of a dye with a stable absorption band, which was the case for both rhodamine B 
and SNARF-5 at the wavelengths used here, but does not apply for all molecular imaging 
agents.  Additionally, SFDI measurements were required before and after adding the 
fluorophore to the diffuse background in order to determine the probe concentration prior 
to calculating the QY, limiting the use of QYI for some real-time applications. Despite 
these requirements and limitations, QYI imaging should still be useful for in vivo 
preclinical imaging, and the methodology is amenable to the use of more complex 
quantitative fluorescence models that would allow for tomographic reconstructions with 
depth resolved information. Additionally, these same methods are applicable to 
quantitative spectroscopic modalities such as frequency and time-domain diffuse optical 
systems if combined with fluorescent measurements, providing deeper tissue depth 
penetration and possible in vivo human applications. 
In summary, QYI is able to extract fluorophore QY regardless of background 
optical properties, highlighting the possibility of using QYI with environmentally sensitive 
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CHAPTER FOUR: IMAGE ARTIFACT CORRECTION IN SPATIAL 
FREQUENCY DOMAIN IMAGING (SFDI) FOR SMALL ANIMAL IMAGING 
 While SFDI is able to provide quantitative tissue optical properties, it has 
limitations when used on objects with highly curved surface. For example, SFDI is 
currently being explored for small animal tumor imaging, but severe imaging artifacts 
occur for highly curved surfaces (e.g. the tumor edge). We propose a modified Lambertian 
angle correction, adapted from the Minnaert correction method for satellite imagery, to 
account for tissue surface normals up to 75°. The method was tested in a hemisphere 
phantom study as well as a small animal tumor model. The proposed method reduced µa 
and µs' extraction errors by an average of 64% and 16% respectively compared to 
performing no angle correction, and provided more physiologically agreeable optical 
property and chromophore values on tumors. 
 
 The work in Chapter Four is published in the Biomedical Optics Express 66 with 
the following contributing authors: 
Yanyu Zhao,1 Syeda Tabassum,2 Shaheer Piracha,1 Mohan Sobhana Nandhu,3 Mariano 
Viapiano,3 and Darren Roblyer1 
1 Boston University, Department of Biomedical Engineering, 44 Cummington Mall, 
Boston, Massachusetts 02215, United States 
2 Boston University, Department of Electrical & Computer Engineering, 8 Saint Mary’s 
Street, Boston, Massachusetts 02215, United States 
3 Brigham and Women's Hospital, Harvard Medical School, 4 Blackfan Circle, 





Spatial Frequency Domain Imaging (SFDI) is a wide-field imaging technique that 
can be used to quantify optical properties (absorption and reduced scattering) of diffusive 
media including biological tissue.26,27 When optical properties at multiple wavelengths are 
measured, tissue chromophore concentrations can be extracted to help identify disease 
states, therapy response, and tissue metabolic function. SFDI is being explored for a 
number of preclinical and clinical applications, including skin flap viability, burn wound 
healing, and subsurface tomography.30–43 
Recently, our group and others have begun to investigate SFDI as a new tool to 
understand the in vivo tumor state in small animal oncology models. The application of 
SFDI to small animal imaging is complicated by the relatively small feature size of the 
tissues of interest, and the relative high surface curvature of subcutaneous tumors, which 
may protrude near-orthogonal to surrounding tissue for some models. Observationally, 
tumor edges, and other surfaces with a high surface normal angle in reference to the camera 
line of sight, suffer from extreme edge artifacts in SFDI, leading to physiologically 
implausible optical properties and chromophore concentrations in these regions. Typically, 
these artifacts manifest as underestimates of diffuse reflectance at low spatial frequencies. 
One potential method to mitigate these artifacts is to eliminate these steep surfaces from 
the data using a threshold method based on tissue angle. Unfortunately, this has the effect 
of censoring large parts of the tumor, which may be unacceptable for many applications.  
Gioux et al. reported a Lambertian correction method for SFDI which could 




divisor term was applied to SFDI data after image demodulation to increase diffuse 
reflectance values for surfaces at tilt angles. This method was shown to improve optical 
property extraction on tissue-simulating phantoms and human hand data, although 
corrections were limited to angles less than 40°. We expand on this work by applying the 
so-called Minnaert Correction, which was first proposed for lunar photometry and later 
developed to angle-correct satellite imagery from the effects of solar illumination angles 
and relative terrain angles.67,68 In the context of SFDI measurements, we refer to this 
correction as the Modified Lambertian Correction (MLC). The MLC is a parameter 
optimization method that adds an additional correction factor to the Lambertian correction 
by empirically accounting for inter-object diffuse reflectance (e.g. light reflected off 
surrounding normal tissue onto the tumor), as well as other possible contributions to 
inaccurate diffuse reflectance values, especially near the tumor edge.  
To validate the MLC method, SFDI measurements were taken on hemispheric 
tissue-simulating optical phantoms with a range of optical properties and different sizes, 
fabricated to mimic the geometry of subcutaneous xenografted tumors. The MLC method 
was compared against non-angle and the standard Lambertian correction for both lower 
angles (<40°) and higher angles (up to 75°). Additionally, MLC was applied to live mouse 
tumor data. Experimental results show that MLC yields similar improvements compared 
to standard Lambertian correction for low angles, and outperforms no-angle correction and 
standard Lambertian correction at higher angles, and MLC provides more physiologically 
reasonable optical property and chromophore values on live mouse tumor data, especially 





4.2.1: Spatial Frequency Domain Imaging (SFDI) 
The details of SFDI image acquisition and processing have been described in detail 
elsewhere.26,27 Briefly, SFDI utilizes spatially modulated sinusoidal light patterns of visible 
or near-infrared light, projected at different spatial frequencies and wavelengths, to 
separate the relative contributions of absorption and scattering in diffusive media. Raw 
reflectance images are sequentially measured, demodulated, and calibrated to create diffuse 
reflectance maps, with pixel values normalized between 0 and 1. Diffuse reflectance (Rd) 
maps are created for each wavelength and each spatial frequency. The spatial frequency 
dependence of Rd at each pixel (i.e. the Modulation Transfer Function) then serves as the 
input to an inverse model, in this case a Monte-Carlo based look-up table method, which 
provides pixel-by-pixel optical absorption and reduced scattering values.28 
Key to the extraction of normalized Rd maps is the calibration of the demodulated 
raw image data (Mac) against a calibration phantom with known optical properties. The 
calibration phantom is first measured with the SFDI system, and a forward model is used 
to determine the expected Rd values based on prior optical property knowledge. A second 
phantom or tissue-of-interest (with unknown optical properties), is then imaged using the 
same spatial frequencies and wavelengths, and calibrated Rd maps are produced using Eq. 
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tis and ref refer to the tissue and calibration phantom, respectively.27 
 
4.2.2: Height correction 
In order to account for reflectance intensity perturbations caused by height 
variation, a previously described height correction method was used.29 Briefly, a 
calibration phantom is measured at multiple heights and the demodulated data (Mac) at each 
height is extracted. Then, a height map of the object or tissue of interest is acquired using 
optical profilometry. A new Mac,ref map is then calculated by adjusting the Mac values, pixel 
by pixel, according to the height versus Mac relationship determined from the multi-height 
calibration measurements. This Mac data is used to replace the calibration Mac,ref term in 
Eq. (1). The effect of height correction is to create a virtual calibration phantom such that 
it has the same pixel-wise height as the object.  
4.2.3: Modified Lambertian Correction (MLC) 
In prior work by Gioux et. al.,29 a Lambertian angle correction was applied as a cosine 
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The angle, θ, refers to the tilt angle of a flat phantom, or more generally, the angle of the 
tissue/phantom surface normal relative to the camera axis as shown in Figure 4.2.1. θ is 
determined for each pixel in the image using an optical profilometry methodology 
previously described.29 The Lambertian correction increases the demodulated image 





Figure 4.2.1: Diagram of angle θ in SFDI imaging geometry. 
 
The proposed MLC method adds a coefficient k to the cosine term, as shown in Eq. 
(3). This coefficient accounts for the object-to-object diffuse reflectance (i.e. reflectance 
from an object’s background onto the object), and potentially other phenomenon not 
accounted for by the standard Lambertian method. When k is equal to 0, no angle correction 
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In order to find an appropriate coefficient k for each Mac map of an object-of-
interest, we propose a parameter optimization method (Eq. 4). Note that for SFDI, there is 
a demodulated Mac map for each spatial frequency and wavelength, and the coefficient k is 
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In Eq. 4, fx, θ, i, and n refer to spatial frequency, surface angle at the pixel location, 
pixel index, and total number of pixels in the optimization region of interest (ROI), 
respectively. The ROI (i.e. the tumor) is manually selected on the uncorrected Mac map. 
Mac, ref is the average Mac value of the low-angle areas with ≤10° thresholding within the 
ROI. It is used as a “gold standard” Mac for the minimization. In a practical sense, the low-
angle area is a region of the ROI where surface angle effects are minimal. The parameter 
optimization will find the k value that minimizes the difference between MLC-corrected 
Mac and Mac,ref for the ROI. The optimization is solved using Newton’s method.
69 The 
determined k value is then applied to all pixels on the object to get the corrected Mac map. 
A different k value is determined for each spatial frequency and wavelength. The corrected 
Mac maps are used to calculate diffuse reflectance maps (Eq. 1), from which optical 
properties and chromophores are determined using Monte-Carlo look-up table method and 
linear fitting, respectively.   
4.2.4: Experimental validation 
The OxImager RS SFDI system (Modulated Imaging Inc., Irvine, CA) was used for 
all optical measurements in this study. This system provides LED illumination at up to 11 
wavelengths spanning the visible to NIR and images with a 15 cm × 20 cm field of view. 
Height correction is applied in data processing.29 SFDI measurements were taken at 526 
nm and 659 nm for phantom studies, and a series of spatial frequencies were used: 0, 0.05, 
0.1, 0.15, 0.2, 0.3, and 0.5 mm-1. The integration time of each image is adjusted from tens 
to hundreds of milliseconds to utilize the dynamic range of the camera.  




measurements were compared using a set of hemisphere tissue-simulating optical 
phantoms. The hemispheres were fabricated using silicone as the base solvent, Nigrosin as 
the absorber, and titanium dioxide (TiO2) as the scatterer. Hemispheres were made with 
diameters of 1 cm, 2 cm, or 3 cm. These diameters were chosen to mimic the expected 
range of preclinical xenograft tumors. The maximum surface normal angle of the 
hemispheres was 75°. Hemispheres were made with a range of optical properties; each 
phantom was homogenous. The optical properties of the phantoms were adjusted by 
varying the amount of absorbers and scatterers.  
First, the effect of different k coefficients on demodulated Mac values for 
measurements on the hemispheres were compared over a line profile taken through the 
center of the hemisphere. Then, the relationship between spatial frequency and optimized 
k values was explored for hemispheres of different sizes, optical properties, and for 
different background phantoms. Then, the root-mean-square-errors (RMSE) of extracted 
µa and µs' were compared for non-angle, standard Lambertian, and MLC correction 
methods for all hemispheres. Errors were compared over a small angle range (<40°), which 
matches the reported range for the standard Lambertian correction, as well as for the full 
angle range (up to 75°). For RMSE calculations, calculations were done using all pixels 
within the angle range being analyzed.  
The angle correction methods were also compared on a mouse tumor model. A 
malignant glioma cell line (GBM34-Lum) were injected subcutaneously on the flank of a 
nude mouse. The tumor was treated with combination of temozolomide and the anti-




anesthesia, 4 days after the end of a treatment session, with a tumor size of 11.6 mm × 10.5 
mm. The mouse was measured at 659 nm, 691 nm, 731 nm, and 851 nm illumination and 
tumor optical absorption and reduced scattering was extracted at these wavelengths. 
Tissue-level chromophore concentrations, including oxy and deoxyhemoglobin, were 
calculated using the extracted optical absorption by linear fitting. All animal procedures 
were approved by the Brigham and Women’s Hospital Animal Care and Use Committee. 
 
4.3 Results 
4.3.1: Optical properties of fabricated hemisphere phantoms 
Fig. 4.3.1 shows white light images and optical properties (at 526nm) of the 2 cm 
diameter hemisphere phantoms. Their optical properties at 526 nm and 659 nm are shown 
in Table 4. The 1 cm and 3 cm diameter hemispheres were made from the same phantom 
batch and had closely matching optical properties. 
 
Figure 4.3.1: White light image of the 2 cm diameter hemisphere phantoms. Optical properties are 




λ Hemisphere #1 #2 #3 #4 #5 #6 #7 #8 #9 
526 nm 
µa (mm-1) 0.014 0.015 0.014 0.027 0.034 0.026 0.051 0.058 0.053 
µs` (mm-1) 1.3 1.7 2.1 1.2 1.4 2.8 1.3 1.5 2.4 
659 nm 
µa (mm-1) 0.019 0.020 0.019 0.037 0.032 0.036 0.066 0.069 0.068 
µs` (mm-1) 0.90 1.4 1.6 0.88 1.0 2.2 0.97 1.3 1.9 
Table 4. Optical properties of the 2 cm diameter hemisphere phantoms. 1 cm and 3 cm hemispheres 
were fabricated from the same batch and had closely matching optical properties. 
 
4.3.2: Mac line profiles for varied k coefficients 
The effect on angle corrected demodulated image data with different MLC k 
coefficients was first explored on hemispheric phantoms. Fig. 4.3.2 shows the line profiles 
of demodulated image data through the center of a 2 cm diameter optically diffusive 
homogeneous hemisphere phantom measured at 526 nm with optical properties of µa = 
0.014 mm-1 and µs' = 1.3 mm
-1. The hemisphere was imaged on a flat background phantom 
with optical properties of µa = 0.053 mm-1 and µs' = 1.2 mm
-1. The left subfigure 
corresponds to SFDI data collected at 0 mm-1 spatial frequency (i.e. DC), whereas the right 
subfigure corresponds to 0.15 mm-1. The dashed black line in the figure represents the 
expected Mac value (i.e. the “gold standard” value) determined by the average Mac of the 
low-angle areas with ≤10° thresholding. The colored lines correspond to angle-corrected 





Figure 4.3.2: Angle-corrected Mac versus coefficient k. 
 
The solid blue line represents the demodulated intensity without any angle 
correction (k=0). For the 0 mm-1 spatial frequency (Fig 4.3.2. Left), Mac values are 
increasingly under-reported as the hemisphere surface normal angle increases from 0° (the 
center of the hemisphere) to 75° (the distal edge of the hemisphere). The red dashed line 
shows Lambertian correction (k=1), which substantially over-corrects the demodulated 
intensity.  For the higher spatial frequency, 0.15 mm-1 (Fig 4.3.2. Right), non-angle 
corrected (k=0) provides a better match to the expected Mac than Lambertian correction 
(k=1) or other non-zero k values. In general, Fig. 4.3.2 visually supports the idea that some 
ideal k coefficient exists, which is spatial frequency dependent, which can minimize angle 
artifacts for homogenous hemispheric phantoms. 
4.3.3: k coefficient determined by parameter optimization  
The effect of spatial frequency and object (hemisphere) and background optical 




coefficient k for a range of spatial frequencies determined by the parameter optimization. 
For the left subfigure, a 2 cm diameter hemisphere phantom (µa = 0.068 mm
-1, µs' = 1.9 
mm-1) was placed on five background phantoms with different optical properties. Each 
combination was measured with SFDI at 659 nm. Each line in the left subfigure represents 
a distinct background optical phantom whose optical properties are listed in the legend. 
The solid blackline represents a black background phantom, which has strong absorption 
and little scattering. The left subfigure shows that the coefficient k approaches 0 at higher 
spatial frequencies regardless of the optical properties of the background phantom. With a 
black background, k approaches 1 (Lambertian correction) for low spatial frequencies. For 
the right subfigure, six 2 cm diameter hemisphere phantoms with different optical 
properties were measured on the same background phantom (µa = 0.053 mm
-1, µs' = 1.2 
mm-1). Fig. 4.3.3 shows that higher overall hemisphere optical attenuation requires higher 
k values and that k values are dependent on object optical properties and imaging spatial 
frequency. 
 




 4.3.4: Comparison of non-angle, standard Lambertian, and MLC on hemisphere 
phantoms  
Comparisons were made between errors in optical property extractions for non-
angle, standard Lambertian, and the MLC method. Fig. 4.3.4 shows the line profiles of the 
absorption and reduced scattering through the center of a 2 cm diameter hemisphere placed 
on a background phantom (µa = 0.053 mm
-1, µs' = 1.2 mm
-1) measured at 526 nm. The 
dashed black line represents the expected µa / µs' values (“gold standard”). The dashed blue 
line, dashed green line, and solid red line correspond to non-angle, standard Lambertian, 
and MLC corrected µa / µs' data, respectively. For absorption, non-angle correction leads 
to overestimation of µa, while the Lambertian correction underestimates µa, causing it to 
be near 0 at the edges of the hemisphere (high angle areas). The MLC corrected µa is very 
close to the gold standard, outperforming the other two methods. For the reduced 
scattering, the non-angle correction and MLC are nearly identical, and both outperform 
standard Lambertian. 
 
Figure 4.3.4: Line profiles of absorption and reduced scattering through the center of a 2 cm diameter 




Fig. 4.3.5 shows 3D absorption and reduced scattering maps rendered for the same 
hemisphere and background phantom. The black arrows indicate the “gold standard” µa / 
µs' values. The 3D visualizations and histograms demonstrate that non-angle corrected data 
skews towards µa values higher than the known value at high angles, and the standard 
Lambertian correction skews towards lower µa values at high angles. Lambertian 
correction also overestimates µs' at high angles, whereas MLC gives µa and µs' values that 
are close to the “gold standard”. It is of note that standard Lambertian correction produces 
a substantial number of pixels with µa values close to 0 mm-1, and µs' values close to 2 mm
-
1, the upper limit of displayed values. In contrast, the MLC data have a tighter distribution 
around the gold standard values, with modest µa underestimates at the extreme hemisphere 
edge. 
 
Figure 4.3.5: Absorption and reduced scattering plots rendered with 3D heights, and histograms of the 




To quantitatively compare non-angle, standard Lambertian, and MLC correction 
methods, groups of hemisphere phantoms with different sizes and optical properties were 
measured at 526 nm and 659 nm. Their µa and µs' values were extracted, the three correction 
methods were applied, and the root-mean-square-errors (RMSE) were calculated for both 
low angles (<40°), and higher angles (up to 75°). Representative RMSE values for the 
larger angle range (up to 75°) are shown in Fig. 4.3.6. Values are plotted as bar plots 
representing the error between the known optical properties and the corrected optical 
properties over the entire hemisphere. This group has nine middle size hemisphere 
phantoms (2 cm diameter), measured at 659 nm. The average µa RMSE of non-angle, 
standard Lambertian, and MLC of this group was 0.026, 0.017, and 0.008 mm-1, 
respectively. For µs' the average RMSE for the three methods was 0.295, 0.387, and 0.256 
mm-1, respectively. The MLC method reduces the µa RMSE by 68.9% and 52.4% 
respectively over non-angle and standard Lambertian correction, and reduces the µs' RMSE 
by 13.2% and 33.9% respectively.  
 Comparing the three methods for angles less than 40° across all hemispheres (n=27) 
and background phantoms (n=5), the overall average µa RMSE of non-angle, standard 
Lambertian, and MLC was 0.0094, 0.0063, and 0.0052 mm-1, respectively.  For µs' the 
overall average RMSE for the three methods for angles less than 40° was 0.16, 0.20, and 
0.15 mm-1, respectively. These results demonstrate improved but comparable error levels 
for the standard Lambertian and MLC methods for smaller angles.   
 The overall average µa RMSE for angles up to 75° across all hemispheres was 




methods was 0.250, 0.454, and 0.209 mm-1, respectively. On average, the MLC method 
reduces the µa RMSE by 63.7% and 49.9% respectively over non-angle and standard 
Lambertian correction, and reduces the µs' RMSE by 15.9% and 51.9% respectively. In 
general, data from all measured hemispheres revealed that the MLC method greatly 
improved µa extractions over the other two methods for larger angles. For µs', MLC did 
little to improve non-angle correction, but as expected, outperformed standard Lambertian 
correction which is not valid at angles higher than 40°. 
 
Figure 4.3.6: RMSE bar plots of 2 cm diameter hemisphere phantoms, measured at 659 nm. 
 
4.3.5: Comparison of non-angle, standard Lambertian, and MLC on live mouse tumors  
Fig. 4.3.7 compares non-angle, standard Lambertian, and MLC on a live mouse 
tumor model. The µa and total hemoglobin concentration were extracted using the three 
methods respectively. The extracted tumor data distributions are also presented in the 
histograms. For non-angle correction, the tumor absorption values skew higher on the 
edges (high angles), with corresponding higher estimated total hemoglobin concentrations. 




values, with corresponding 0 µM total hemoglobin values at these areas. Although “gold 
standard” values are not available for the mouse tumor, the extracted data distributions are 
tighter with the MLC method, and µa and total hemoglobin values are physiologically 
plausible throughout the tumor ROI. 
 
Figure 4.3.7: Comparison of three methods on mouse tumor data and their distributions shown in 
histograms, measured at 659nm, 691 nm, 731 nm, and 851 nm. The plotted absorption data was 
measured at 659 nm.  Optical properties are only shown for the tumor ROI. Zoomed-in figures are 
shown for the tumor optical absorption and total hemoglobin. 
 
4.4 Discussion and conclusion 
MLC correction for SFDI reduced µa extraction errors over a range of phantom 
hemisphere dimensions and optical properties by an average of 63.7% compared to 
performing no angle correction. Additionally, in contrast to non-angle correction and 
standard Lambertian correction, MLC produced optical property and chromophore 
extractions that better match physiologically reasonable values on a xenograft mouse tumor 
model, especially at the tumor edge. The empirical approach taken here to determine k 




measurement, or input of background optical properties or instrument geometry, allowing 
it to be practically implemented in tumor monitoring studies regardless of specific 
instrument used and with little additional analysis effort. 
The experiments performed in this study revealed that angle related effects in SFDI 
are dependent on the optical properties of the object of interest and background, the spatial 
frequency, the wavelength, and the imaging surface normal angle. For example, it was 
demonstrated that lower k values are required at high spatial frequencies, and almost no 
angle correction (k=0) was required for spatial frequencies of 0.3 mm-1 and above. This 
suggests that data collected at higher spatial frequencies are less affected by both 
Lambertian effects and inter-object reflections. Since higher spatial frequencies are 
preferentially sensitive to tissue optical scattering,27,70 µs' data is preserved even without 
angle correction (i.e. k = 0), which was demonstrated by the relatively low RMSE values 
observed in scattering data when no angle correction was used. At DC, greater correction 
was required and k approached 1 (i.e. Lambertian correction) when the diffusive phantom 
was imaged on a dark, highly absorbing background. When hemisphere phantoms were 
imaged on a diffuse background, intermediate correction (i.e. 0 < k < 1) was required as 
the standard Lambertian correction significantly overcorrected Rd values for surfaces at 
higher angles. This is likely due to the inter-object reflections occurring between the 
background phantom and the hemisphere, which increase measured light intensity at the 
hemisphere edge. These angle dependent inter-object reflections have previously been 
described in the context of correcting satellite imagery.68 At low AC spatial frequencies 




dominate. Although not explicitly explored in this work, effects related to the increase in 
projected imaging spatial frequency on the highly curved surfaces likely contribute to edge 
effects.   
There are several limitations of the MLC correction method related to the 
assumptions required for its implementation. For example, the MLC method assumes that 
the Mac value of low-angle areas are representative of the entire region or object-of-interest, 
and large heterogeneities are likely to introduce errors. Specifically, under scenarios where 
low angle zones are not available or there are large inherent heterogeneities, the 
optimization could be invalid. Despite this limitation, MLC provided better optical 
property and chromophore extractions on actual tumors compared to non-angle or standard 
Lambertian corrections at the tumor edge. Another limitation is that the hemisphere 
phantoms tested here were fabricated with a maximum 75° surface normal relative the 
vertical since the angle dependence relationship of Rd above 75° deviated from the 
relationship observed below 75°, possible because of noise in the optical profilometry data 
or due to more complex interobject effects. It is of note that the mouse tumors imaged for 
this study had almost no pixels >75°, suggesting this may not be a limiting factor for small 
animal tumor imaging. Finally, MLC was only tested for a limited set of geometric shapes, 
and the method was tested only for corrections on a limited region-of-interest within the 
field-of-view (i.e. the tumor).  
In the future, MLC will be tested for its ability to correct optical property 
extractions from more complex object geometries with spatially varying optical properties 




general trends observed in this study relating k to object and background optically 
properties and spatial frequency may allow for simpler implementations under constrained 
conditions, such as a limited range of optical properties throughout the field-of-view and 
known background optical properties.   
The MLC method described here is likely to be useful for small animal tumor 
imaging as it provides a relatively simple method to recover high-angle data that would 
otherwise have to be censored from the data set. The application of MLC to SFDI for 
longitudinal drug response studies in subcutaneous mouse tumor models may allow for the 
identification of prognostic optical biomarkers of therapy response and resistance that can 
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CHAPTER FIVE: LABEL-FREE, NON-INVASIVE MAPPING OF TISSUE 
WATER AND LIPID CONTENT 
 Non-invasive quantification of functional tissue biomarkers has broad implications 
in basic research, pre-clinical studies, and in clinical practice. Optical methods are well 
suited to this task, based on the characteristic absorption signatures of chromophores 
including oxy/deoxyhemoglobin, water, lipid, and glucose. Yet, quantitative in vivo 
mapping of biomarkers such as water and lipids still remains a challenge, due to turbidity 
of biological tissues and limited accessibility by NIR. Here, we demonstrate for the first 
time, a new method for label-free in vivo mapping of water and lipid with shortwave 
infrared (SWIR) structured illumination. We first validated the accuracy of extracting 
water and lipid concentrations in phantom models.  We then examined the capabilities of 
our system in multiple pre-clinical and clinically-relevant settings. For example, we 
dynamically tracked the concentration of water (i.e. edema) in superficial tissues during 
induced inflammation in a small animal model. Next, we imaged water and lipids in 
preclinical tumors, and validated the results using histologic staining. Further, we identified 
in vivo small animal interscapular brown adipose tissues within intact skin, demonstrating 
the potential for longitudinal studies of obesity and thermoregulation. Finally, we 
highlighted monitoring of blood lipids content in human volunteers, and validated the 




5.1: Label-free, Non-invasive Mapping of Water and Lipid Content in Tissue with 
shortwave-infrared SFDI 
 The work in part 5.1 is to be submitted to a scientific journal with the following 
contributing authors: 
Yanyu Zhao,1 Matthew Applegate,1 John Jiang,1 John Paul Dumas,2 Mark Pierce,2 and 
Darren Roblyer 1 
1 Boston University, Department of Biomedical Engineering, 44 Cummington Mall, 
Boston, Massachusetts 02215, United States 
2 Rutgers, The State University of New Jersey University, Department of Biomedical 
Engineering, 599 Taylor Road, Piscataway, New Jersey 08854, United States 
5.1: Introduction and Background 
The ability to non-invasively map the concentration of functional tissue 
components with high spatio-temporal resolution is important in many areas of basic 
research, pre-clinical studies, and in clinical practice. Alterations in oxy/deoxy-
hemoglobin, water, lipid, collagen, glucose, and other components are known to be 
implicated in major diseases including cancer, atherosclerosis, diabetes, and 
stroke.2,5,22,23,71 Current methods for quantifying these components are often limited to 
single-point, spatially averaged values derived from extracted fluids and tissue samples.72 
Optical spectroscopy has long been used to estimate the absorbance of species 
within dilute solutions, across the UV-VIS-NIR wavelength range. This approach has been 
extended to allow measurements in turbid media, including biological tissues in vivo.8,73,74 




to determine the absorption and scattering coefficients of tissue. These techniques are most 
often implemented using fiber-optic probes to deliver light to and from the tissue, yielding 
a single measurement averaged over the volume of interrogated tissue.   
Spatial frequency domain imaging (SFDI) is an emerging technique that allows for 
tissue absorption and reduced scattering coefficients to be quantitatively mapped across an 
entire region of tissue.27 SFDI works by projecting structured illumination patterns onto 
the tissue surface, measuring the remitted light on a camera, and using a calibrated phantom 
to establish the diffuse reflectance of the tissue at each spatial frequency. Determining the 
diffuse reflectance at more than one spatial frequency allows tissue optical properties to be 
decoupled and quantified using an appropriate inverse model.   
Absorption and reduced scattering spectra can be constructed with SFDI, again as 
spatially-resolved 2D maps. The measured absorption spectrum represents the combined 
effect of multiple absorbers within tissue, but if these components exhibit distinct 
absorption spectra, the measured spectrum can be decomposed into concentration-
dependent contributions from the primary chromophores.46  
To-date, SFDI has been implemented in the visible (VIS) and near-infrared (NIR) 
spectrum (400 – 900 nm).  This has allowed in vivo wide-field mapping of oxy- and deoxy-
hemoglobin as these chromophores have absorption spectra with distinct features in the 
NIR region.41,43,75 However, other important biomarkers, including water, lipid, and 
collagen, lack distinct absorption features in the VIS-NIR, instead displaying strong 
absorption bands in the shortwave infrared (SWIR) region (900 – 2,000 nm).47,76 Therefore, 




to these chromophores.   
Previous attempts have been made to extend SFDI into the shortwave infrared range 
by extrapolating measurements from the NIR out to longer wavelengths.77 However, the 
optical properties were fit by planar illumination rather than measured from structured 
illumination for most SWIR wavelengths. A few other works explored SFDI for extraction 
of water content.30,78,79 However, validation (e.g. in phantom models) was yet conducted 
for such extraction of water contents. In addition, no lipid measurements were available in 
prior SFDI studies.  
 
5.2: Methods and materials 
Here, we demonstrate SFDI across VIS-NIR-SWIR wavelengths with 1 nm central 
wavelength resolution from 680 – 1,300 nm, as illustrated in Fig. 5.5.1a. A liquid phantom 
composed of blood, oil, and water is measured, as shown in Fig. 5.1.1b. Hyperspectral 
optical absorption cubes are generated for both NIR and SWIR wavelengths. The 
hemoglobin area shows distinct absorption features in the NIR, while the oil area shows 
maximum absorption at 1,210 nm in the SWIR. Absorption spectra are plotted in single 
pixel locations from blood, oil, and intralipid, respectively. It shows that blood has strong 
absorption in the NIR compared to water and lipid. In contrast, the oil area has the highest 
absorption at 1,210 nm, which corresponds to the lipid absorption peak in the SWIR 
wavelengths. With measured NIR absorption, maps of oxy-hemoglobin and deoxy-
hemoglobin concentration can be reconstructed using Beer’s law. The maps of water and 




information, as shown in Fig. 5.1.1c. We also conducted phantom studies to validate the 
concentration extraction of water and lipid. The measured absorption (µa) and reduced 
scattering (µs') spectra of a series of homogenous phantoms with varying water and lipid 
concentrations are shown in Fig 5.2.1a,b respectively. The extracted water and lipid 
concentrations are compared with known ground truth in Table 5. The average error for 
water concentration extraction is 1.9 %, and the average error for lipid is 1.1 %.  
Intuitively, the reduced scattering should increase with increasing scattering 
content in optical phantoms. However, this is not the case for the lipid phantoms in Fig. 
5.2.1 b. This is potentially due to particle interactions under relatively high concentrations 
or electric charges.80 This could also be due to that the distance between particles is 
comparable or less than the wavelength under high scatterer concentrations. In addition, it 
has been shown in previous study that the reduced scattering of lipid phantoms may not 
increase with higher lipid content.81 
The effective penetration depth of SFDI is dependent on tissue optical absorption 
and scattering: (𝜆) = 1 √3𝜇𝑎(𝜆)[𝜇𝑎(𝜆) + 𝜇𝑠′(𝜆)]⁄ ,
27 the improved penetration depth was 
benefited from decreased scattering intensity at SWIR region. In addition, based on optical 
properties in literature, 78 we identified SWIR penetration window near 1,100 nm in bio-
tissues (Fig. 5.2.2a). 82 This improved penetration depth at 1,100 nm was also confirmed 
with Monte Carlo simulations (Fig. 5.2.2b). To experimentally demonstrate the improved 
penetration depth within turbid media at SWIR region compared to NIR, we conducted a 
phantom study where tubes containing absorbing mixture were placed at depths from 1 mm 




exhibits the same absorption at 680 nm and 1,100 nm, while the background liquid 
phantom also has the same absorption at 680 nm and 1,100 nm (Fig. 5.2.2d). The 
absorption maps and line profiles (Fig 5.2.2e,f respectively) show that absorption contrast 
can be measured at increased depths at 1,100 nm compared to at 680 nm. In addition, 
signal-to-background ratio (SBR) is quantitatively compared for the two wavelengths in 
Table 6. It shows that SBR can be increased with SWIR wavelength at all four tube depths. 
In particular, at 4 mm depth, while the NIR 680 nm can no longer detect absorption 
contrast, the 1,100 nm SWIR wavelength still has a 1.2 SBR.  
In the rest of this work, we demonstrate longitudinal mapping of tissue water 
content in an in vivo small animal model of simulated edema as well as inflammation. We 
illustrate the use of SWIR-SFDI for measuring lipid biomarker in a tumor xenograft. In 
addition, we demonstrate the ability of SWIR-SFDI to non-invasively map brown adipose 
tissue (BAT) within intact skin in a small animal model, biomarker of topical relevance in 
the fields of body thermoregulation and metabolism. Finally, we highlight the capacity of 
SWIR-SFDI to non-invasively probe blood lipids in humans, verified with blood draw and 
lipid panel. 
 
Figure 5.1.1: Hyperspectral SWIR-SFDI system and mapping of endogenous chromophores. In the 




structured illumination patterns at 0, 120, and 240 onto the sample plane. Backscattered light is 
collected by the camera. Orthogonal polarizers are positioned to remove specular reflection from 
images. The raw reflectance images are then demodulated, calibrated, and mapped with a Monte-
Carlo Look-Up-Table to obtain optical properties (absorption and reduced scattering) at each 
wavelength. Here a liquid phantom is made by having soybean oil on top of intralipid, and a semi-
circular blood phantom at the top of the oil. The liquid phantom is measured at both NIR and SWIR 
wavelengths and optical properties are extracted (shown for absorption). Hyperspectral absorption 
spectra at blood, oil, and intralipid locations are plotted respectively. Hemoglobin and lipid absorption 
features are clearly visible in the spectral plots. Chromophore maps for oxy-hemoglobin, deoxy-
hemoglobin, water, and lipids can be extracted from the measured optical absorption. 
 
5.2.1 Design of a hyperspectral SWIR-SFDI system 
The system diagram and data processing steps are shown in Fig. 5.1.1a. The 
primary components of the system are an ultrafast pulsed laser, tunable from 680 – 1,300 
nm in 1 nm increments (InSight DS+, Spectra-Physics, Santa Clara, California), a digital 
micro-mirror device (DMD) (CEL5500 Light Engine, Digital Light Innovations, Austin, 
Texas), and a TriWave germanium camera with spectral sensitivity over the 300 – 1,600 
nm range (Infrared Laboratories, Inc., Peabody, MA). In order to reduce collection of 
specularly reflected light from samples, a linear polarizer (VersaLight™, Meadowlark) 
was placed in front of the projection lens, with a second polarizer, orthogonal to the first, 
in front of the camera lens.   
While the laser operates as a mode-locked femtosecond pulsed source, it effectively 
serves as a continuous wave light source in the SWIR-SFDI setup, due to the camera 
integration times used.  The output beam is expanded to a collimated diameter of 2.5 cm 
before illuminating the DMD, which is imaged on to the sample plane with ×8.3 
magnification by a 75 mm focal length projection lens. Illumination is generated by 
programming the DMD with planar (DC, 0 mm-1) and structured (sinusoidal, 0.1 mm-1) 




0°, 120°, 240° phases at each wavelength across the tuning range of the laser source.  
Demodulated images are calculated for each of these two spatial frequencies at each 
illumination wavelength according to I = (I0
2 + I120
2 + I240
2)1/2.27 Demodulated images are 
finally converted to diffuse reflectance images by normalizing to a calibrated phantom. 
Optical absorption and reduced scattering coefficients are estimated at each wavelength 
from a look-up table generated by Monte-Carlo simulations with diffuse reflectance at 0 
mm-1 and 0.1 mm-1 as inputs.27 Concentrations are then extracted by fitting absorption 
values at multiple wavelengths using known basis spectra for each chromophore.46 
 
5.2.2 Phantom preparation and imaging 
Liquid phantoms were made with varying ratios of water and lipid contents. The 
lipid content is provided by Intralipid (State Surgical Supply, Siloam Springs, AR, USA) 
and soybean oil (Sigma-Aldrich, St Louis, MO, USA). The soybean oil is mixed with 
Triton X-100 (Sigma-Aldrich, St Louis, MO, USA) as an emulsifying agent.72 Mixtures 
were blended for 1 min to obtain homogeneous phantoms. Water concentration varied from 
90% to 60%, with lipid concentration varying from 10% to 40%. SWIR-SFDI 
measurements were conducted at wavelengths from 900 – 1,300 nm in 5 nm increments. 
The measured optical property spectra were smoothed in Fig. 5.2.1a and Fig. 5.2.1b for 
visualization by a simple moving average (n = 3). The calibration phantom for these 
measurements was made of 10% Intralipid, whose optical properties were obtained from 
previous studies.44,45 




liquid phantoms were composed of water, nigrosin (Sigma-Aldrich, St Louis, MO, USA), 
NIR dye (NIR1054WD, QCR Solutions Corp, Port St. Lucie, FL, USA), and TiO2 (Sigma-
Aldrich, St Louis, MO, USA). The absorbing tubes were made with ~10× absorption 
compared to the background phantom (Fig. 5.2.2d). The absorbing tubes were made from 
hollow tubes filled with 0.05 g/L nigrosin and 0.055 g/L NIR dye solution. The background 
phantom was made with 0.061 g/L nigrosin solution with sonicated TiO2. Optical property 
maps were measured at 680 nm and 1,100 nm, with 0 mm-1 and 0.1 mm-1. 
 
5.2.3 Optical absorption of water-lipid phantoms 
The absorption of water-lipid phantoms was calculated as the sum of absorption of 
individual chromophores (water and lipid). The absorption of each chromophore is 
calculated as chromophore concentration × extinction coefficient spectra, where the 
concentration is known when making the phantoms, and the chromophore spectra are 
available in literature. 44,45 The error of optical absorption measurements is determined as 
a percentage average of the difference between the measured values and the known values. 
 
5.2.4 In vivo water monitoring study for simulated edema 
BALB/c mice (Charles River Laboratories, Cambridge, MA, USA) were used in 
the study in accordance with an institutionally approved protocol and federal guidelines. 
Hair was removed before the measurements. Simulated edema was induced by 
subcutaneous injection of 10% phosphate-buffered saline (PBS). An amount of 0 ml, 0.1 




Baseline measurements were taken before injection, and longitudinal measurements were 
taken every 5 minutes for a 2-hour duration post-injection. The mice were maintained 
under anesthesia throughout the experiment. SWIR-SFDI measurements were conducted 
from 970 – 1,270 nm with 60 nm increments to extract water content. 0 mm-1 and 0.1 mm-
1 spatial frequencies were used in the measurements. 
 
5.2.5 In vivo water monitoring study for acute inflammation 
BALB/c mice (Charles River Laboratories, Cambridge, MA, USA) were used in 
the study in accordance with an institutionally approved protocol and federal guidelines. 
Hair was removed before the measurements. TPA (12-O-Tetradecanoylphorbol 13-acetate, 
Sigma-Aldrich, St. Louis, MO, USA) was dissolved in acetone (Sigma-Aldrich, St. Louis, 
MO, USA) with a concentration of 1 μg/μl. A dosage of 10 μl TPA solution was injected 
to a group of mice (n=4) to induce acute inflammation. 83,84 The same amount of PBS was 
injected to the control group (n=4). Baseline measurements were taken before the injection, 
and longitudinal measurements were taken every 5 minutes for a 2-hour duration post-
injection. The mice were maintained under anesthesia throughout the experiment. SWIR-
SFDI measurements were conducted from 970 – 1,270 nm with 60 nm increments to extract 
water content. 0 mm-1 and 0.1 mm-1 spatial frequencies were used in the measurements. 
The white blood cells counting were conducted with Bright-Line Hemacytometer (Hausser 
Scientific, Horsham, PA, USA). The preserved tissues were sectioned and H&E stained by 
the Specialized Histopathology Core of Dana-Farber / Harvard Cancer Center. The stained 




5.2.6 Ex vivo mapping of tumor lipid content 
The PC3/2G7 prostate tumor xenograft model was used for this study.70 The 
PC3/2G7 cells were grown and expanded at 37°C in a humidified 5% CO2 atmosphere in 
RPMI-1640 culture medium containing 7% fetal bovine serum. 100 Units/ml penicillin and 
100 μg/ml streptomycin cells were split in 1:3 or 1:4 when cells reached 70-80% 
confluence to maintain holoclone-forming ability (approximately one passage every 3 
days). Severe combined immunodeficient (SCID) hairless outbred mice (SHO 
MouseCrl:SHO-PrkdcscidHrhr), age 5 to 6 weeks old (21-23 gram), were purchased from 
Charles River Laboratories (Cambridge, MA, USA), and housed in the Boston University 
Laboratory Animal Care Facility in accordance with an institutionally approved protocol 
and federal guidelines. Autoclaved cages containing food and water were changed once a 
week. On the day of tumor cell inoculation, 4 × 106 PC3/2G7 cells were subcutaneously 
injected on the posterior flank of a SCID mouse in 0.2 ml serum-free RPMI using a U-100 
insulin syringe with a 28.5-gauge needle. Tumor length (L) and width (W) was measured 
every 3 days. Tumor volume was calculated as Vol = (π/6) × (L × W)3/2. After volume 
exceeded 3000 mm3, the tumor was rapidly resected and cut in half. The cut face of the 
tumor was imaged by SWIR-SFDI at wavelengths from 910 nm – 1,290 nm, with 20 nm 
increments. The edges of the tumor cross-sections were marked with green and yellow 
permanent inks to help guide later co-registration of microscopic analysis. After imaging, 
the tissue was snap frozen and sectioned at 10 μm thickness. The sections were stained 
using Oil Red O with hematoxylin counterstain for lipid content.85 The stained sections 




sections from three tumor samples were measured and stained for lipid content in this 
study. In the histology slide, the green ink mark was identified and then starting there a 
rectangular ROI across the tumor sample was imaged by the microscope. The width of the 
ROI is approximately 1.1 mm. For each tumor sample, the rectangular ROI was separated 
into 10 sub-areas to calculate individual lipid fractions, and then compared with 
corresponding areas on the lipid content map measured by SWIR-SFDI. The lipid fraction 
is defined as number of lipid pixels divided by total number of pixels. The staining of the 
tissue slides was conducted by the Specialized Histopathology Core of Dana-Farber / 
Harvard Cancer Center. Images of the stained slides were later read by a certified 
pathologist from the same institution to confirm identification of lipid pixels.  
In order to automatically identify pixels representing lipid in all the microscopic 
images, over 1,800 pixels were first manually labeled as lipid or non-lipid by visual 
inspection in those images (the labeling was confirmed by certified pathologist). Then we 
compared two classification methods: simple thresholding and nearest-neighbor. We 
randomly separated the labeled data as training set and test set. The training set was 
composed of 500 lipid pixels and 1,000 non-lipid pixels. The test set was composed of 150 
lipid pixels and 150 non-lipid pixels. For the thresholding method, we explored both RGB 
space and HSV space of the data, and identified that thresholds in the HUE channel could 
best separate the two classes with 92.6% and 91.1% accuracies for lipid and non-lipid, 
respectively on the training set. On the test set, the thresholding method had 80% and 
93.3% performance for lipid and non-lipid samples, respectively. For the nearest-neighbor 




into a 6-channel vector with RGB channels normalized to [0, 1]. The classification was 
conducted by searching for closest pixel in the training set with Euclidean distance. It 
achieved 100% accuracy in the training set and 98.0% accuracy for both classes in the test 
set. For all the microscopic images, we applied the nearest-neighbor classification on each 
pixel and generated binarized lipid maps where lipid pixels were labeled as 1. The lipid 
fractions were then calculated from those binarized lipid maps as ratio of the number of 
lipid pixels with the total number of pixels in the image.   
 
5.2.7 In vivo identification of brown adipose tissue 
A total of ten healthy C57BL/6 mice (Charles River Laboratories, Cambridge, MA, 
USA) were included for brown adipose tissue classification study. Adipose tissues were 
excised at anatomical locations known to contain brown and white fat.86 These BAT and 
other tissue samples were imaged with SWIR-SFDI from 900 nm – 1,300 nm, yielding 
measurements of optical absorption and reduced scattering with 5 nm spectral increments. 
From these 81 measured wavelengths, a subset was selected by a feature selection 
algorithm: 1,145 nm, 1,205 nm, and 1,245 nm.87 SWIR-SFDI measurements at these three 
wavelengths were then used to train a support vector machine (SVM) classifier to identify 
BAT. 88 Only data of pixels from the training set mice (n=7) was used in wavelength 
selection and training the classifier. The trained SVM was tested on adipose tissue data 
from another three mice. Under anesthesia, in vivo measurements were conducted for those 
mice, and the same SVM was used to distinguish BAT from other tissues through skin.87 




classification. The preserved tissues were sectioned and H&E stained by the Specialized 
Histopathology Core of Dana-Farber / Harvard Cancer Center. The stained slides were read 
by a certified pathologist from the same institution. 
 
5.2.8 Blood lipids study in humans 
This study was conducted in accordance with an institutionally approved protocol 
and federal guidelines. Ten human subjects were measured with SWIR-SFDI in the 
morning and afternoon of 5 hours apart the measurements, respectively, at 730 nm – 1250 
nm with 40 nm increments and 0 mm-1 and 0.1 mm-1 spatial frequencies. Blood draws were 
conducted immediately after each measurement by a professional phlebotomist (Boston 
Clinical Laboratories, MA, USA), and lipid panel analysis was performed by the same 
company. The chemical analysis on blood draws was considered gold standard in this 
study. The total blood lipids content from lipid panel (triglycerides + total cholesterol) was 







Figure 5.1.2: Non-invasive in-vivo monitoring of water content for simulated edema and acute 
inflammation. a, Three dosages of PBS were respectively applied to individual groups of mice (n=4). 
Color-coded water content changes at the injection site are shown on a representative mouse of each 
group. Star sign represents the location of injection. b, Time series of the mean and standard deviation 
of the mean values of all four mice in each group. For the 0 ml group, there was no significant water 
content changes of before and after the injection (p=0.94). For the 0.1 ml and 0.2 ml groups, both had 
significant water content changes of before and after the injection (p=7.9e-5 and p=6.2e-5, 
respectively). c, A dosage of 10 µl PBS and TPA were respectively applied to two groups of mice (n=4). 
Changes of water content are color-coded and shown on a representative mouse of each group. d, Time 
series of the mean and standard deviation of the mean values of all four mice in each group. For the 
10 µl PBS group, the water content gradually decreased after the initial injection. In contrast, for the 
10 µl TPA group, the water content continued increasing after injection, indicating accumulation of 
water content and potential inflammation (later confirmed with histology analysis by certified 
pathologist). At the end of monitoring the water content of the two groups are significantly different 
from each other (p=0.0035). e, Blood samples were collected from tail vein for all mice in both PBS and 
TPA groups, at before the injection and 5 hours after injection. White blood cells (WBCs) as indicator 
of inflammation were counted and the changes in WBCs were compared. The TPA group shows 
significant increase in WBCs compared to the PBS control group (p=0.0038). 
5.3.1 In vivo water content monitoring 
Tissue water content is an important indicator for edema and inflammation.23 In 




model of simulated edema (Fig. 5.1.2a). Different amounts (0 ml, 0.1 ml, and 0.2 ml) of 
PBS were subcutaneously injected to mice in each group (n=4). Fig. 5.1.2a demonstrates 
representative mice from each group with changes of water content mapped on fur-free 
area of the mouse body right after injection. The 0 ml mouse shows no increase of water 
content, and the 0.1 ml mouse shows a moderate increase. As expected, the 0.2 ml mouse 
shows the highest increase in terms of measured water content. Fig. 5.1.2b demonstrates 
time series of the mean and standard deviation of the mean values of changes of water 
content around injection site for all four mice in each group. The 0 ml group has relatively 
stable water content over the course of monitoring. The 0.1 ml and 0.2 ml groups both have 
significant increase of water content caused by the injection, and the water content 
gradually decreases after the injection.  
To further demonstrate water content monitoring for a physiological process, acute 
inflammation was induced by injection of 10 µl TPA, and the same amount of PBS was 
used in the control group, as shown in Fig. 5.1.2c. Changes of water content 2 hours after 
the injection was mapped on body fur-free area for representative mice from both groups. 
The water map for the PBS mouse shows that 2 hours after the injection, only slight 
increase of water content can be observed. In contrast, the TPA mouse shows large increase 
of water content caused by the injection of 10 µl liquid. Fig. 5.1.2d demonstrates the time 
series of the water content around injection site for the two groups. For the PBS group, the 
water content gradually decreased towards baseline after the injection. In contrast, for the 
inflammation (TPA) group, water content continued to increase after the injection, and then 




the TPA group, blood samples were collected from tail vein of all mice in both PBS and 
TPA groups, at before the injection and 5 hours after injection. White blood cells (WBCs) 
as indicator of inflammation were counted (Supplementary Table 7) and the changes in 
WBCs were compared, as shown in Fig. 5.1.2e. The TPA group shows significant increase 
in WBCs compared to the PBS control group (p=0.0038). In addition, after the imaging 
measurement, tissues from injection site were cut and preserved. The tissue samples were 
then stained with H&E. The stained tissue slides were rated by certified pathologist. 
Presence of cellular acute inflammation was found in samples of TPA group, although in 
some samples the signs of inflammation was minimal, potentially due to the fact that the 
mice were sacrificed only 5 hours after exposure to TPA. No signs of cellular acute 





Figure 5.1.3: Ex vivo mapping lipid in tumor. a, Tumor cells are inoculated in small animal and the 




mapping. The tumor samples (n=3) are then sectioned, stained, and imaged under bright-field 
microscope for lipid fraction analysis. b, White-light image of a representative tumor cross-section. 
Green and yellow marks are made by permanent inks for co-registration with histology slides. c, Lipid 
content map measured by SWIR imaging. The red box indicates corresponding area on the histology 
slide for lipids correlation. Microscopic images are collected from the histology slide area and 
corresponding binarized lipid maps are generated, as shown in (d). d, The imaged histology slide area 
is divided into 10 sub-areas and lipids fraction is calculated as the number of lipids pixels over the total 
number of all pixels, in each sub-area image. e, Correlation plot of SWIR-SFDI results and histology 
staining. X-axis shows lipid content measured by SWIR-SFDI, and Y-axis shows lipid fraction 
identified by microscopic images. Black dashed line indicates the best fit line. The Pearson correlation 
coefficient of the lipid results is 0.64, indicating agreement of histology results with SWIR-SFDI 
measurements. Colour of data points corresponds to cross-sections from three different tumors. 
 
5.3.2 Ex vivo mapping of tumor lipid content 
Phenotypic and functional heterogeneity is known to exist among cancer cells 
within the same tumor, as a consequence of genetic change, environmental differences and 
reversible changes in cell properties.89 The role of intra-tumor heterogeneity in predicting 
therapeutic response and tumor progression has recently been brought to attention.90,91 
There is a growing recognition that intra-tumor heterogeneity within the same patient is 
clinically relevant for making treatment decisions.89 Improved scientific approaches are 
therefore still needed to probe tumor heterogeneity and further study drug response 
biomarkers.89,92 
Figure 5.1.3 demonstrates ex vivo mapping of lipid content in a subcutaneous tumor 
model using SWIR-SFDI. The study procedures are illustrated in Fig. 5.1.3a. After 
inoculation and development, the tumor was cut in half and imaged with SWIR-SFDI. 
Tissue samples were collected for sectioning and lipid staining, and then imaged with 
bright-field microscopy. While visual heterogeneity can be observed in the white light 
image (Fig. 5.1.3b), SWIR-SFDI unveils qualitative heterogeneities in biomarker spatial 




the microscopic image, illustrated in Fig. 5.1.3d. Binarized lipids map of other tumor cross-
sections are shown in Fig. 5.2.3. Quantitative measurement of tumor lipid content 
determined by SWIR-SFDI was compared to lipid content in Oil Red O stained tumor 
sections. Rectangular regions of interest (ROIs) across the cut face of the bisected 
specimens were analyzed for 3 tumor samples, and correlated with SWIR-SFDI results 
(Fig. 5.1.3e). These corresponding ROIs in the SWIR-SFDI lipid concentration map 
exhibited strong correlation with levels of lipid composition identified by microscopic 
staining. 
 
Figure 5.1.4. In vivo classification of brown adipose tissue. A machine learning framework is designed, 
implemented, and verified for identifying in vivo brown fat within intact skin. In the training phase 
(n=7), mouse skin is removed and brown adipose tissue as well as other tissues are extracted. 
Hyperspectral (900 – 1,300 nm) SWIR-SFDI data is collected for the ex vivo tissues. With a wavelength 
feature selection algorithm, three wavelengths are selected to train an SVM classifier for identifying 
brown adipose tissue. In the test phase (n=3), SWIR-SFDI data is collected at selected wavelengths 
with the mouse hair shaved and the skin being intact. Within the region-of-interest (ROI) indicated by 
the yellow dashed line, the SVM classifier is used to map subcutaneous BAT on a per-pixel basis (green 
overlay) non-invasively in vivo. For verification, the mouse skin was removed after SWIR-SFDI 




predicted brown fat and other tissues were stained with H&E, and imaged under bright-field 
microscope. The data shows that the SVM prediction matches the histology results (confirmed by a 
certified pathologist). 
 
5.3.3 In vivo identification of brown adipose tissue 
Brown and white adipose tissue (BAT and WAT, respectively) are the two major 
types of adipose tissue.  BAT is well-known for its role in thermoregulation and anti-
obesity,93,94 while WAT is primarily responsible for storage of energy and providing 
thermal insulation.86 Being present in most adults,95 BAT has also been found to contribute 
to longevity.96 WAT is predominantly found in the subcutaneous and visceral areas of the 
body, while BAT is located primarily at the interscapular area and in the large blood vessels 
of the thorax.86 On the cellular level, brown adipocytes may appear and develop in WAT 
in response to thermogenic stimuli in a process termed the "browning" of WAT.97,98 
Here we demonstrate the use of SWIR-SFDI for non-invasive in vivo differentiation 
of brown adipose tissue from other types of tissues such as white adipose tissue. First, 
hyperspectral SWIR-SFDI data from seven C57BL/6 mice were used to select a subset of 
wavelengths where the measured absorption coefficients exhibit the potential to 
discriminate between BAT and other tissue types.87 The top three performing wavelengths 
(1145 nm, 1205 nm, and 1245 nm) were applied to data from another three mice, 
demonstrating feasibility of separating BAT and other tissues by their spectral features 
(Fig. 5.1.4 upper panel). A support-vector-machine (SVM) was trained to distinguish 
BAT,88 achieving over 87% accuracy on out-of-sample test data. The trained SVM 
classifier was applied to each pixel within a defined region of interest in a dataset acquired 




lower panel, subfigure 3) agrees well with the anatomical distribution of BAT in mice.86 
For verification, the mouse skin was removed after imaging, and tissue samples were 
collected from predicted brown fat and other tissue type areas. The predicted brown fat and 
other tissues were stained with H&E. The stained slides were imaged with bright-field 
microscope and the prediction results were confirmed by certified pathologist. 








Figure 5.1.5. Blood lipids measurement on human subjects. a, Blood lipid study protocol. After 10 
hours overnight fasting, the subjects are measured with SSI in the morning, immediately followed by 
a blood draw. A high-fat meal is then provided to the subjects as breakfast. Five hours later, another 
measurement and blood draw are conducted. Blood lipids (triglycerides and cholesterol) content 
obtained from the blood draws are considered gold standard in this study. b, Correlation of absolute 
blood lipid values between SSI measurements and blood draws. With 20 data points being measured 
from both modalities, the correlation coefficient is 0.70, indicating a strong correlation and agreement 
of SWIR-SFDI measurements with the gold standard. c, Correlation of the changes in blood lipids 
content between SWIR-SFDI measurements and blood draws. With 10 subjects being measured from 
both modalities and at two time points, the correlation coefficient is 0.63, which shows strong 
agreement between the SWIR-SFDI measurements and the gold standard. d, A map of changes in lipid 
content on the subject’s hand. Structural features of hand vessels are clearly visible in the lipid map, 
indicating a higher increase of lipid content in the veins compared to non-vascular tissues. 
 
5.3.4 Non-invasive blood lipids monitoring in humans 
Blood lipids level is known to correlate with cardiovascular disease.99 Currently in 
order to determine blood lipid levels, invasive methods such as blood draws are required 
in the clinics. To demonstrate SWIR-SFDI for non-invasive measurement of blood lipids, 
we measured the hand of human subjects, and compared the results from blood draws (with 
lipid panel). Furthermore, while high-fat diets are known to cause increase in blood 
lipids,100 we longitudinally measured those healthy volunteers before and after a high-fat 
meal, and compared with blood draws. Fig. 5.1.5a demonstrates the blood lipid study 
procedures. Blood lipids were measured twice for each subject, respectively in the morning 
before the high-fat meal, and 5 hours later in the afternoon. The measured lipid content 
levels at both time points are shown in Fig. 5.1.5b. Obvious increase in blood lipid content 
were observed by SWIR-SFDI, which matches the lipid panel results from blood draws 
(Table 8). In addition, the total blood lipids from blood test and SWIR-SFDI measured 
lipid content are compared in Fig. 5.1.5c, with a strong correlation of 0.70 (n=20). In 




also compared in Fig. 5.1.5d, with a strong correlation of 0.63 (n=10). Moreover, a lipid 
subtraction map from a representative subject is derived by subtracting reconstructed lipid 
concentration map of 5 hours after meal, from the lipid concentration map of the baseline 
(before meal). Areas of blood veins are clearly visible, and it highlights the increase of 
lipid content in the veins, as shown in Fig. 5.1.5e. 
 
5.4: Discussion 
We have shown for the first time in vivo simultaneous mapping of water and lipid 
with a SWIR-SFDI system. Building such a system brought challenges in instrumentation, 
such as light source, structured illumination, and camera. The light source needs to be 
tunable and have hyperspectral capability. The illumination component needs to be able to 
project flexible structured patterns, from VIS-NIR to SWIR regions. The camera should be 
sensitive to a broad wavelength range, breaking the sensitivity limitation of regular silicon 
detectors. To overcome those difficulties, we used a tunable pulsed laser and a Germanium 
camera to project and collect structured light patterns from VIS-NIR to SWIR region (up 
to 1,300 nm).  
The system was first validated with a phantom study and demonstrated for 
increased penetration depth in the SWIR region. We also demonstrated in vivo water 
content monitoring as a potential application for studying inflammation and edema. It has 
been shown in previous study that water and lipid are important biomarkers for tumor.2,3,23 
We then measured an ex vivo tumor for those biomarkers, with validation by microscopic 




absorption, this is better done at wavelengths where individual chromophores have high 
absorbance and not obscured by other chromophores.46 As described in previous literature, 
notable shortwave infrared absorption features of tissue constituents including water, 
lipids, and collagen are much more prominent than their counterparts in visible and 
NIR.44,45,47 Therefore, SWIR wavelengths are essential for accurate extraction of 
biomarkers, such as water and lipid in the tumor.  
With importance to body thermoregulation and metabolism, we demonstrated in 
vivo distinguishing of brown adipose tissue with intact skin on a small animal model. Such 
capability has important application potentials. Accumulation of excess WAT has 
deleterious consequences for metabolic health.94 The development of beige adipocytes in 
WAT (browning) would raise energy expenditure and reduce adiposity.101 Thus, being able 
to detect BAT over WAT and other tissues opens the potential of longitudinal monitoring 
of ‘browning’ which is related to the reduce of adverse effects of WAT and could help to 
improve metabolic health.94 
Finally, we demonstrated in vivo probing of blood lipids in humans, with 
importance to cardiovascular risk monitoring. In addition, for patients with high 
concentration of lipids in the blood, lipid-lowering therapy with statins is widely used in 
the clinics to reduce the risk of cardiovascular events as well as overall mortality in primary 
and secondary preventions.102,103 However, with a lack of convenient blood lipids 
monitoring, it has been shown that overtreatment and undertreatment for hyperlipidemia 
are frequent in clinical practice.103 Therefore, the demonstrated system can potentially be 




There are other potential applications of the SWIR-SFDI system, such as surgical 
guidance, tumor biology, and surgeries (skin flaps).34,75,104 
 
5.2: Supplementary Materials  
 The work in part 5.2 is to be submitted as supplementary document for part 5.1 with 
the following contributing authors: 
Yanyu Zhao,1 Matthew Applegate,1 John Jiang,1 John Paul Dumas,2 Mark Pierce,2 and 
Darren Roblyer 1 
1 Boston University, Department of Biomedical Engineering, 44 Cummington Mall, 
Boston, Massachusetts 02215, United States 
2 Rutgers, The State University of New Jersey University, Department of Biomedical 
Engineering, 599 Taylor Road, Piscataway, New Jersey 08854, United States 
 
 
Figure 5.2.1. a, Measured optical absorption (µa) spectra of water-lipid phantoms. Absorption spectra 
of 100% water and 100% lipid are also plotted in (a) for reference. At the water absorption peak of 
970 nm, the measured optical absorption increases with elevated water concentration in the phantoms, 
and at the lipid peak of 1,210 nm, the measured absorption also increases with lipid concentration. b, 
Measured optical scattering (µs) spectra of the phantoms. It can be observed that the measured optical 





Table 5. Extracted water and lipid content from water-lipid phantoms. Water and lipid concentrations 
are extracted from SWIR-SFDI measurements by fitting the optical absorption spectra, then the 
extracted concentrations are compared with known concentrations. The average error for water is 






Figure 5.2.2. Increased penetration depth with SWIR wavelengths. a, SWIR penetration window near 
1,100 nm is identified by calculating SFDI effective penetration depth using mouse data. 78 It shows 
that SWIR wavelengths can significantly improve penetration depth compared to the NIR window. b, 
Improved penetration depth at SWIR window verified by Monte Carlo simulations. Depth statistics 
for both wavelengths and spatial frequencies are presented as 90% photon visitation depths. The depth 
statistics show 1.31 mm probing depth at DC for 680 nm and 2.42 mm depth for 1,100 nm, respectively. 




background liquid phantom, at 1 mm – 4 mm depths. d, Calculated absorbance spectra of absorbing 
tubes (red line) and background liquid phantom (blue line), respectively. The absorbance spectra were 
calculated based on spectrophotometer measurements of nigrosin, water, and NIR dye. e, Optical 
absorption maps measured at 680 nm and 1,100 nm wavelengths.  f, Line profiles of measured optical 
absorption corresponding to the dashed white lines in (e). 
 
 









Figure 5.2.3. Tumor cross-section lipid maps from SWRI-SFDI and histology microscopic images. a, 
SWIR imaging lipid map of tumor #2 of Fig. 5.1.3d. Histology image and corresponding binarized lipid 
map are shown for the red rectangular ROI. b, SWIR imaging lipid map of tumor #3 of Fig. 5.1.3d. 




#1 #2 #3 #4 #1 #2 #3 #4 
Before 13,200 13,700 14,400 9,800 12,500 11,800 9,800 12,200 
After 11,000 11,200 11,200 9,700 18,000 13,300 12,500 14,500 











Morning Afternoon Morning Afternoon Morning Afternoon Morning Afternoon 
#01 52 61 160 159 61 60 81 77 
#02 135 290 167 169 46 42 89 88 
#03 61 142 111 119 60 60 35 36 
#04 136 182 227 219 46 49 126 126 
#05 163 159 184 182 63 62 96 91 
#06 80 253 144 146 62 55 46 44 
#07 46 56 199 193 64 62 125 118 
#08 92 141 170 166 62 57 89 84 
#09 64 82 190 188 49 47 119 118 
#10 76 105 154 156 52 54 83 82 







Figure 5.2.4. Classification and verification of in vivo brown fat identification. a, The trained SVM is 
applied on out-of-sample mouse for brown fat identification. The predictions are verified with H&E 
of tissue samples. b, The trained SVM is applied on another mouse for brown fat identification. H&E 





CHAPTER SIX: DEEP LEARNING INVERSE MODEL FOR SPATIAL 
FREQUENCY DOMAIN IMAGING (SFDI) 
 Spatial frequency domain imaging (SFDI) becomes increasingly popular as it is 
able to provide quantitative and wide-field tissue optical properties, as well as and 
chromophore concentrations. SFDI conducted with 2 spatial frequencies (2-fx) has been 
widely used in pre-clinical and clinical studies. It has been known that with multiple 
frequencies (multi-fx) the estimation of optical properties can be more accurate with 
reduced uncertainty. However, performing SFDI with multi-fx is limited in practice, with 
the major bottleneck being the speed of inversion from measured diffuse reflectance (Rd) 
to optical properties. We present a deep learning solution that solves the inverse problem 
in a fast and accurate manner. Particularly, we present the deep learning model with similar 
or improved optical property inversion accuracy than previous methods. We also 
demonstrate that the proposed method is ×300 – ×100,000 faster than the other methods. 
Combined with real-time data acquisition techniques, the proposed deep learning inverse 
model may enable immediate hemodynamic information and surgical guidance in the 
clinic.  
 
 The work in Chapter Six is to be submitted to a scientific journal with the following 
contributing authors: 
Yanyu Zhao,1 Yue Deng,2 Feng Bao,3 and Darren Roblyer 1 
1 Boston University, Department of Biomedical Engineering, 44 Cummington Mall, 




2 Samsung Research, 665 Clyde Avenue, Mountain View, CA 94043, Mountain View, 
California 94043, United States 
3 Tsinghua University, Department of Automation, Beijing, 100084, China 
6.1: Introduction 
Tissue optical properties including absorption (µa) and reduced scattering (µs′) can 
provide important information about tissue oxygenation and molecular 
composition.31,46,105,106 Being able to map such information is useful in both pre-clinical 
and clinical scenarios.31,32,63,75 Spatial Frequency Domain Imaging (SFDI) is an emerging 
technology that allows quantitative measurements of tissue optical properties (OPs).26,27 It 
has been widely used in a number of biomedical applications, such as small animal 
imaging, burn wound monitoring, clinical tissue flap monitoring.30,39,42,43,63,75,107 
In order to separate absorption from scattering, SFDI requires a minimum of 2 
spatial frequencies (2-fx) for the inversion from diffuse reflectance (Rd) to optical 
properties (OPs). In this process, the tissue spatial-frequency-dependent response is 
calibrated against a phantom with known optical properties to determine tissue Rd values 
at corresponding spatial frequencies, which is then used to extract optical properties. In the 
case of 2-fx, Rd will be a 2-d vector, and optical properties can be extracted by interpolating 
Rd with a Look-Up-Table (LUT) generated by Monte Carlo simulations.
27,28 While SFDI 
data collection can be relatively fast (up to tens of milliseconds), this inversion process 
from Rd to OPs is relatively slow, especially when more than 2 spatial frequencies are used.  
Angelo et al. reported a fast inversion method for SFDI, which could speed up the 




forward model. The measured Rd is then compared to each sample in the new LUT, and 
OPs of the closest sample is assigned as the estimated OPs of the measured tissue. While 
being fast, the accuracy of the method depends on the density of the pre-computed LUT. 
If densely sampled, the computational speed will be compromised. In addition, this method 
was only for the case of 2-fx.  
While using 2-fx in SFDI can separate absorption from scattering, it may cause 
uncertainty problems in the extracted OPs.109 For 2-fx, although spatial frequency 
combination, such as [0, 0.1] mm-1, may be optimized to reduce the estimation uncertainty, 
this is limited to a relatively small range of optical properties.75 In contrast, the strategy to 
use a combination of multiple spatial frequencies, such as [0, 0.05, 0.1, 0.2, 0.4] mm-1, in 
the inversion of OPs can help minimizing the error as well as the impact of uncertainties 
of diffuse reflectance measurement. 110 Moreover, the use of above spatial frequencies (5-
fx), can significantly reduce uncertainties in the extracted optical properties in some OP 
ranges of the tissue, as shown in Fig. 6.1.1.109 The upper panel shows estimation 
uncertainties of µa and µs′, respectively, when SFDI is conducted with only 2-fx. Each point 
in the plot represents a combination of optical properties. The colored stars in the plots 
represent literature optical property values of different biological tissues.46,111–117 The 
lower panel is the counterpart of the upper panel, showing estimation uncertainties when 
SFDI is conducted with 5-fx ([0, 0.05, 0.1, 0.2, 0.4] mm-1). The uncertainty plots show that 
for some tissue optical properties, measurement uncertainty can be over 15% with 2-fx. In 





Figure 6.1.1. Estimation uncertainties of extracted optical properties for 2-fx and 5-fx, respectively.109 
 
Therefore, compared to 2-fx, the use of 5-fx in SFDI is beneficial in that it can 
improve estimation uncertainty of OPs for a number of biological tissues and in a larger 
range of optical properties. However, this does not come for free. While data collection of 
SFDI can be relatively fast for both 2-fx and 5-fx, it is important to note that different than 
the 2-fx, the inversion from Rd to OPs with multiple spatial frequencies, such as the 5-fx, 
is an iterative process, which can be time consuming. Although the method proposed by 
Angelo et al. could potentially be expanded to multi-fx, the accuracy as well as speed will 
still both be limited by the density of the pre-computed LUT.  
Deep learning is a computational technique that has been successfully applied in 




medical image analysis, board games, video games, and many others.118–123 The power of 
deep learning lies partially in its ability to automatically detect and approximate nonlinear 
patterns in the high dimensional space with proper optimization algorithms, as well as 
training samples and corresponding labels.118 For example, in the detection of diabetic 
retinopathy in retinal fundus photographs, training samples are the retinal fundus images, 
and the corresponding labels are disease grading generated by ophthalmologists.121 The 
deep learning model will then learn a high-dimensional mapping from training samples to 
their labels. Note that such ability is ideal for the sake of multi-fx SFDI inversion. 
Therefore, in this paper we propose a deep neural network (DNN) inverse model for multi-
fx SFDI, which can estimate µa and µs′ simultaneously. The DNN method was tested on a 
large range of OPs, and compared with existing multi-fx iterative method. We also 
expanded the fast inversion method by Angelo et al. from 2-fx to 5-fx (referred as nearest-
search), and then compare with the proposed method. Experimental results show that DNN 
yields comparable or better accuracy than iterative method, and improves computational 
speed by multiple orders of magnitude. 
 
6.2: Methods 
6.2.1: Spatial frequency domain imaging (SFDI) 
The details of SFDI image acquisition and data processing have been describe in 
detail elsewhere.27 Briefly, SFDI instrument projects spatially modulated sinusoidal light 
patterns onto the tissue, and at the same time raw reflectance images are captured by the 




property extraction. After collected by the camera, the raw reflectance images at different 
spatial frequencies are demodulated and calibrated with a phantom of known optical 
properties, to get diffuse reflectance at each spatial frequency, denoted as Rd. The Rd at 
each pixel then serves as input to the inverse model, which provides extraction of optical 
absorption and reduced scattering values at corresponding pixels. The inversion from Rd to 
OPs can be based on a Monte Carlo model (refer as “MC”) or a diffusion equation model 
(refer as “diff”). Note that the raw reflectance of the tissue is captured as images, therefore 
relatively fast. In contrast, the inverse model is applied pixel-by-pixel in the Rd images, 
which is therefore the bottleneck of speed in the dataflow of optical property extraction. 
 
Figure 6.2.1. Diagram of SFDI instrument and illustration of SFDI dataflow for optical property 
extraction. 
 
6.2.2: Inverse methods 
 Existing inverse method for multi-fx SFDI operates in an iterative manner, as 
shown in Fig. 6.2.2a. First, initial guess on OPs is made, and the corresponding theoretical 
Rd is generated by a forward model, which can be either MC or diff, as discussed in 




is minimized by the iterative algorithm. The OPs will be updated to generate new Rd values 
to further reduce the difference until convergence is reached for the minimization. Finally, 
the corresponding OPs from the Rd of convergence will be the output of the iterative 
process and considered as the OPs of the measured tissue. In previous literature this method 
has been implemented with the “fminsearch” function in Matlab (MathWorks Inc, Natick, 
MA, USA).27  
In addition, we adopted the inverse method originally proposed for 2-fx by Angelo 
et al., and expanded it to multi-fx, as shown in Fig. 6.2.2b. First, possible combinations of 
OPs are sampled and sent to the forward model to generate a corresponding Rd set. The 
measured Rd is compared to each Rd vector in the pre-computed Rd set under Euclidean 
distance. The corresponding OPs of the closest Rd vector will be determined as the 
extracted optical properties. This method is also implemented in Matlab and the pair-wise 
Euclidean distance is calculated using the “pdist2” function in Matlab.  
In contrast to the above two methods, the proposed deep learning inverse model 
(DNN) takes the measured Rd as input, and directly output OPs. 
 





6.2.3: Deep neural network inverse model 
The structure of the proposed DNN model is shown in Fig. 6.2.3a. The input of the 
model is the Rd values at different spatial frequencies. Here we demonstrate the case of 5-
fx discussed in section 6.1 and previous literature.110 The model has 6 fully-connected 
hidden layers and there are 10 neurons in each layer. The activation function is a hyperbolic 
tangent sigmoid transfer function, which is nonlinear and maps data from (-∞, +∞) to (-
1, 1). The model outputs both µa and µs′ simultaneously.  
The training data was generated by the “white” Monte Carlo model, with µa 
sampled from 0.001 mm-1 to 0.25 mm-1 using 0.001 mm-1 increments, and µs′ sampled from 
0.01 mm-1 to 3 mm-1 using 0.01 mm-1 increments.28 The spatial frequencies were [0, 0.05, 
0.1, 0.2, 0.4] mm-1, as discussed in above sections. The training of the deep learning model 
used Matlab neural network toolbox as well as TensorFlow with Keras as high-level API. 
Hyperparameters such as number of layers and number of neurons were tuned in Keras 
using Adam optimization with an initial learning rate of 0.001 and batch size of 128. To 
reduce potential overfitting, Levenberg-Marquardt optimization with Bayesian 
regularization was used in the Matlab neural network toolbox. The training was completed 
after 2000 epochs. Finally, the trained model was implemented in Matlab in order for speed 
comparison. After training of the DNN model, a number of 10,000 combinations of OPs 
were randomly selected in the range of [0, 0.25] mm-1 for µa and [0, 3] mm
-1 for µs′, and 
corresponding 5-fx Rd values were generated by the MC forward model for the test of the 
trained model. The expected OPs and estimated OPs are demonstrated in Fig. 6.2.3b. The 




blue dots. Fig. 6.2.3b shows that the outputs of the DNN match closely with expected 
ground truth values, indicating no signs of overfitting of the neural network.  
 
Figure 6.2.3. Structure of proposed deep learning model and estimations on randomly generated test 
data. 
 
6.2.4: Comparison on randomly generated data 
In order to compare the iterative, nearest-search, the proposed DNN method, a new 
test set of 10,000 combinations of OPs were randomly generated in the range of [0, 0.25] 
mm-1 for µa and [0, 3] mm
-1 for µs′, and corresponding 5-fx Rd values were generated by 
the MC forward model. The above inverse methods were used to process the test set for 
the inversion of Rd to OPs. Both MC and diff as forward model were used in the iterative 




above methods. In addition, in order to test inversion performance with existence of noise, 
a separate test set was made by adding 0 mean and 2% Gaussian noise on the Rd values. 
The computation was conducted on a desktop computer with Intel i7-7700K 4.20GHz CPU 
and 16 GB RAM. 
 
6.3: Results 
6.3.1: Comparison of Iterative method, nearest-search, and DNN on accuracy 
Fig. 6.3.1 shows the extracted optical properties against their expected values 
without noise on the Rd values. Each blue dot represents an optical property data point. The 
red line in each subplot represents the identify prediction line, where a perfect OPs 
estimation should be located exactly on it. The mean and standard deviation values of 
percent errors of extracted OPs are shown in each subplot. Fig. 6.3.1b shows the results of 
the iterative method using diffusion equation as the forward model, which gives relatively 
the worst accuracy among all methods. The nearest-search method in Fig. 6.3.1c has better 
performance than the diffusion equation iterative method, but worse than the DNN and 
iterative MC method. Fig. 6.3.1d shows the results of the proposed DNN method, which is 
better than the diffusion equation iterative method and the nearest-search method. It also 
has similar performance compared to the MC iterative method.  
Fig. 6.3.2 shows the extracted optical properties against their expected values with 
2% Gaussian noise on the Rd values. The diffusion equation iterative method still has the 
worst performance. The nearest-search method has slightly worse accuracy than the MC 




Notably, the proposed DNN method achieves better performance than the MC iterative 
method with smaller estimation error and variance. 
 
Figure 6.3.1. Comparison of accuracy for the inversion from Rd to OPs without noise. 
 
 





6.3.2: Comparison of iterative method, nearest-search, and DNN on speed 
Table 9 shows the speed comparison of the inversion methods where each 
computation was repeated 10 times. For a total of 10,000 inversions from Rd to OPs, the 
MC iterative method took over 670 seconds, while the other iterative method using 
diffusion equation as forward model took 15.6 s. The nearest-search method took 1.7 s 
which was faster than both versions of iterative methods. The proposed DNN method only 
took 0.0050 s, which was two orders of magnitude faster than the nearest-search, three 
orders of magnitude faster than the diffusion equation iterative method, and five orders of 
magnitude faster than the MC iterative method. Such speed improvement is also true when 
processing larger scale inversions with 696×520 data points. 
 







10000 673.60±15.32 s 15.62±0.10 s 1.70±0.087 s 0.0050±6.4e-4 s 
696×520 39412.34±8744.94 s 467.08±4.85 s 60.16±0.69 s 0.23±0.0085 s 
Table 9. Comparison of speed for the inversion from Rd to OPs. 
 
6.4: Discussion and Conclusion  
With noise-free Rd values, the MC iterative method shows similar accuracy with 
the DNN method due to the fact that the iterative searching algorithm is able to effectively 
search entire optical property space in a continuous manner. In contrast, the proposed DNN 
model was only trained with a relatively sparsely sampled data points from the optical 
property space (250 × 300). The diffusion equation iterative method shows worst accuracy, 




than the Monte Carlo.  
The accuracy of nearest-search and DNN can both potentially be improved with 
more densely sampled OPs in the optical property space. With both accuracy and speed as 
metrics, the DNN method outperforms existing methods as well as other modified fast 
inversion method. In addition to the 5-fx demonstrated in this work, we expect the proposed 
deep learning framework can be adopted and trained for other combinations of spatial 
frequencies as well.  
Being able to perform fast optical property extraction for multi-fx SFDI can be 
useful for real-time SFDI applications with enhanced accuracy performance, and reduced 
uncertainty in extracted OPs.124,125 Given pre-determined wavelengths and proper training 
data, one could also go directly from multi-fx Rd input values to chromophore 
concentrations, such as hemodynamic values, which makes real-time feedback for surgical 
guidance possible.  
In this work, we introduced a deep learning framework in multi-fx SFDI for fast 
and accurate inversion of diffuse reflectance to optical properties. The proposed method 
shows outstanding accuracy compared to previous methods. The proposed method is also 





CHAPTER SEVEN: CONCLUSIONS AND FUTURE WORK 
 The final chapter summarizes the conclusions of this body of work, offers ideas for 
related future work, and presents some additionally preliminary results.  
7.1: Summaries 
 Chapter 3 presents fluorophore quantum yield mapping in diffusive media. A 
fluorescence correction model is applied based on measured tissue optical properties by 
SFDI. Fluorophore quantum yield in diffusive media such as tissues can be estimated from 
the corrected fluorescence. This method is shown to have accurate results on fluorophore 
quantum yield estimation. It is also demonstrated to be effective on different fluorophores. 
This method has potential application on probing tissue potential local environment such 
as pH or temperature.  
 Chapter 4 proposes and validates an image artifact correction algorithm for SFDI. 
It is shown that compared to previous method, more accurate optical properties and 
chromophore extraction can be achieved with the proposed correction algorithm for SFDI, 
when applied to objects that have highly curved surface geometry.  
 Chapter 5 presents SFDI in the SWIR wavelengths and enables extraction of 
widefield biomarker information, such as water and lipid content in tissues. Multiple 
applications are demonstrated with the proposed SWIR-SFDI system. Water content is 
dynamically monitored in simulated edema and inflammation in small animal model. Lipid 
content on small animal tumor is also measured and validated with histology staining. In 
vivo classification of adipose tissue type through intact skin is demonstrated. Last, the 




results are compared with blood draws with a lipid panel.  
 Chapter 6 addresses the bottleneck of SFDI processing. A deep learning framework 
is designed and validated. The SFDI inversion speed from diffuse reflectance to optical 
properties is improved by ×300 – ×100,000.  
 
7.2: Future Work 
 The work in this thesis provides many potential future directions, a few of which 
are discussed here: 
1. The fluorophore quantum yield mapping presented in Chapter 3 has potential as an 
in vivo tool. Tissue local environment such as temperature and pH can potentially 
be non-invasively measured with this method. With a pH sensitive dye such as 
SNARF-5, pH in small animal tumor model may be extracted and monitored 
longitudinally in a new way. Furthermore. Fluorophores such as ICG that are FDA-
approved can also be explored for in vivo human applications.  
2. Chapter 5 presents in vivo mapping of water and lipid with shortwave infrared 
wavelengths. In particular, blood lipid measurements are correlated with blood 
draw lipid panel. This highlights the possibility of non-invasive longitudinal blood 
lipids monitoring with this technique. With a two-layer model that takes into 
account the superficial skin-layer, blood lipids can potentially be measured with 
improved accuracy.  
3. In addition to simultaneous mapping of water and lipid content using SWIR 




range can also be probed, such as collagen. The spectral un-mixing in the presence 
of multiple chromophores is likely to be challenging.  
4. Deep learning has been proven useful in many other fields, and there will be 
increasingly more applications in biomedical optics as well. Chapter 6 
demonstrates deep neural network to speed up SFDI optical property inversion by 
×300 – ×100,000. This framework can also be extended to other inverse problems, 
such as the optical property inversion in digital diffuse optical spectroscopic 
imaging (dDOSI), where the post-processing being a major bottleneck for the speed 
of tissue information extraction. Potentially it can also be applied to diffuse optical 
tomography in 3-D optical property reconstruction for tissues.  
 
7.3: Preliminary results 
 This section presents some preliminary results based on the possible futures 
direction in previous section. 
7.3.1: Extraction of Collagen Concentrations with SFDI  
 Collagen is an important protein and is also the most abundant in humans.126 
Similar to lipids, it has absorption features in the shortwave infrared. 45 Here measurement 
on real tissues is conducted and a theoretical analysis of collagen concentration estimation 
is discussed.  
 In addition, in order to simulate the spectral un-mixing of water, lipid, and collagen, 
a theoretical analysis is conducted. Figure 7.3.1 shows percent error of simulated 




sampled with water in the range of 5% – 90%, lipid in the range of 1% – 90%, and collagen 
in the range of 1% – 90%, where the total of the three components remains 100%. 
Specifically, known extinction spectra of those chromophores are sampled to generate 
theoretical µa at 900 – 1300 nm, with either 5 nm or 40 nm increments. Then 2% Gaussian 
noise is added to the µa spectra. Chromophores are reconstructed using Beer’s law with the 
noisy spectra and then compared to the ground truth. The goal of the simulation is to get a 
sense of how the extraction accuracy potentially relates to the wavelength density in 
measurement. Fig. 7.3.1 shows that in the 900 – 1300 nm wavelength range, even with 81 
wavelengths, with 2% Gaussian noise in the absorption, the percent error could still be 
relatively high for collagen. With fewer wavelengths, the average percent error for collagen 
can be over 10%. This simulation study shows that collagen extraction is challenging with 
spectral un-mixing in the presence of multiple chromophores. In order for an accurate 
collagen concentration estimation, potentially more wavelengths or lower measurement 






Figure 7.3.1. Percent error of simulated chromophore extraction with water, lipid, and collagen. 
 
7.3.2: superfast deep neural network inverse model digital Diffuse Optical Spectroscopic 
Imaging (dDOSI) 
 As discussed in previous section, in addition to multi-fx SFDI optical property 
inversion, deep learning can potentially be used as a general fast inversion framework in 
other optical imaging modalities as well. Here a superfast inversion model based on deep 
neural network for digital Diffuse Optical Spectroscopic Imaging (dDOSI) is presented. 
dDOSI is a novel optical technology that allows fast measurement of tissue optical 
properties.127 The data acquisition for dDOSI can be up to 97 Hz. However, the bottleneck 
of this technology is the inversion from measured data to tissue optical properties, since 
the inversion is based on iterative computations.127 In order to speed up the inversion 
process, a deep neural network (DNN) inverse model is designed and validated in Fig. 




method and the DNN. It demonstrates that the DNN has similar or better accuracy 
performance than the iterative method. Speed wise, 10 and 100 measurements are 
simulated and repeated 10 times to compare the speed of optical property inversion from 
the measured amplitude and phase data, shown in Table 10. It demonstrates that the DNN 
inverse model improves the computational speed by two to three orders of magnitude. Such 
speed increase opens possibility of real-time tissue information extraction with dDOSI. 
Fig. 7.3.3 demonstrates dDOSI measurements on a human thumb. The optical absorption 
and hemoglobin fluctuations are clearly visible with heart pulsing. The measurements were 
conducted at approximately 25 Hz. Real-time feedback of such information is now possible 
with the DNN inverse model.  
 
 






# measurements (s) 
Iterative method DNN 
10 0.21 ± 0.034 4.9e-4 ± 4.7e-4 
100 2.7 ± 0.074 5.6e-4 ± 4.3e-4 
Table 10. Speed comparison of the iterative method and DNN for dDOSI optical property inversion. 
 
 
Figure 7.3.3. Thumb measurements of dDOSI. Hemoglobin information is extracted from the 
measured absorption. The measurements were conducted at approximately 25 Hz. Absorption and 
oxy-hemoglobin pulses from heart pulsing are clearly visible.  
 
7.4: Conclusion 
 The body of this work has aimed to build novel instrument, improve methodology, 
expend applications, and incorporate technology in other fields to enhance current imaging 
techniques. Biomedical optics has great potential to provide additional tissue information 
in the clinic and improve patient outcomes. Additional work needs to be done toward this 
goal. However, it is not only the technology advancement, but also habit nurturing, product 
cost, and marketing that hold the prosperity of biomedical optics in the real world. As an 
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